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INTRODUCTION
 Historically, the fungi were regarded as relatively insignificant causes of 
infection and only until recently did clinical laboratories offer little more than 
passing interest in providing mycologic services. It is now well documented 
that  the  fungi  are  common  causes  of  infection,  particularly  in  immuno 
compromised patients.
The  incidence  of  fungal  infections  is  increasing  at  an  alarming rate, 
presenting an enormous challenge to healthcare professionals. This increase is 
directly related to the growing population of immunocompromised individuals, 
resulting  from  changes  in  medical  practice  such  as  the  use  of  intensive 
chemotherapy,radiotherapy  and  immunosuppressive  drugs.  HIV  and  other 
diseases  which  cause  immunosuppression  have  also  contributed  to  this 
problem.
Systemic fungal  infections  may be caused by either  an opportunistic 
organism that infects an at-risk host, or may be associated with a more invasive 
organism that is endemic to a specific geographical area. Systemic infections 
can be life threatening and are associated with high morbidity and mortality. 
Because diagnosis is difficult and the causative agent is often confirmed only at 
autopsy, the exact incidence of systemic infections is difficult  to determine. 
The  most  frequently  encountered  pathogens  are  Candida  albicans and 
Aspergillus spp.  but  other  fungi  such  as  non-albicans  Candida spp.  are 
increasingly important.
OVER VIEW OF CLINICAL MYCOLOGY
 More than  50,000 valid  species  of  fungi  exist.  But  only  100 or  150 
species are generally recognized as a cause of disease in human beings. Human 
beings  become  an  accidental  host  by  inhalation  of  spores  or  by  their 
introduction into tissue by trauma. Except for the dimorphic fungi, humans are 
relatively resistant to infection caused by the fungi.
The major factor responsible for the increase in the number of fungal 
infections has been an alteration in the immune system.  Whether caused by the 
introduction of immunosuppressive agents or serious underlying diseases, this 
alteration may lead to infection by organisms that are normally considered to 
be non pathogenic. Such infections occur in patients with 
 debilitating diseases such as diabetes
 infection with HIV                            
 impaired  immunologic  function  resulting  from 
corticosteroid therapy and cytotoxic chemotherapy.
 long term antimicrobial chemotherapy 
 long term intravenous cannulation
 gastro intestinal surgical procedures
 malignancies  
 organ transplantation 
It  is  because  of  the  need  to  provide  effective  health  care  to  immuno 
compromised that laboratories now must be able to identify and report all fungi 
from clinical specimen.
GENERAL   FEATURES   OF   FUNGI
 Fungi  can  generally  be  classified  into  three  groups  based  on  the 
appearance of the colonies formed.
Yeast & yeast like fungi produce moist, creamy, opaque or pasty colonies on 
media. 
Moulds or filamentous fungi   produce fluffy, cottony, woolly or powdery 
colonies.
Dimorphic  fungi   exhibit  either  yeast  or  yeast  like  (35°C  –  37°C)  and 
filamentous form (25°C – 30°C).
Several pathogenic fungi are dimorphic fungus. Some of the medically 
important  yeasts,  particularly  the  Candida spp.  may  produce  yeast  forms, 
pseudohyphae and / or true hyphae. The polymorphic feature of this group of 
organisms is not temperature dependent.
Yeasts
Yeasts are unicellular organisms that are round to oval and range in size 
from  2-60µm.  Candida are  oval  yeasts  2-6µm× 3-9µm  in  size.  The 
microscopic morphological features usually appear similar for different genera 
and are not particularly helpful in their separation. However, the size, presence 
or absence of a capsule, or  narrow necked budding are features that can be 
helpful in separation of Cryptococcus species from Candida species.
Most of the important yeasts and yeast like organisms may belong to the 
Ascomycota, the Basidiomycota or the Deuteromycota.
In  general  the  yeasts  reproduce  asexually  by  blastoconidia  formation 
(budding) and sexually by the production of ascospores or basidiospores. The 
process of budding begins with a weakening and subsequent out pouching of 
the  yeast  cell  wall.  This  process  continues  until  the  daughter  cell  (bud)  is 
completely formed. The daughter cell usually detaches from the mother cell by 
a septum and a residual defect occurs at the site of budding; this is known as a 
bud scar
Alternatively, if the out pouching is tubular without the constriction at 
its base, a  germ tube is  formed, the initial stage of true hyphae formation. 
Pseudohyphae represent elongated buds that  have failed to separate and are 
connected  to  one  another  to  create  a  “links  of  sausage” appearance. 
Pseudohyphae  will  have  cell  wall  constriction  rather  than  true  intracellular 
septations, delineating the fungal cell borders. 
TAXONOMY
Berkhout structured the genus  Candida in 1923 to separate the fungi 
then known as Monilia species into two groups. Plants associated molds still 
classified in genus Monilia, and yeast associated with warm blooded animals 
reclassified as Candida species.
The  genus  name  Candida was  formally  given  the  status  of  nomen 
conservandum at  the International Botanical  Congress in Montreal  in  1959. 
Under  its  current  definition,  yeasts  of  basidiomycetous  affinity  have  been 
excluded  from  the  genus,  so  that  all  Candida spp.  are  now  yeasts  of 
ascomycetous affinity.7
Taxonomic  revisions  lead  to  flow  of  additions  and  subtractions  of 
species name from the list  of  the  “medical  Candidas”.  Several  yeasts  that 
earlier  enjoyed  separate  species  status  are  now recognized as  synonyms  of 
C.albicans, viz. C.stellatoidea, C.clausenii and C.langeronii.
 In  1995  a  new  species,  C.dubliniensis was  defined  from  Dublin, 
Ireland.  It  differs  from C.albicans  in  the  non-reactivity  of  its  DNA with  a 
C.albicans specific  molecular  probe.156 Morphologically  and  physiologically 
the phenotype of C.dubliniensis closely resembles that of C.albicans differing 
only  in  minor  properties.  This  new species  would  never  be  recognized  in 
laboratories  that  depend on germ tube  test  to  differentiate  C.albicans from 
other  yeasts,  since  germ tube  formed  by  C.dubliniensis is  indistinguishable 
from those of  C.albicans.  C.dubliniensis colonies have a  darker green hue 
than those of  C.albicans on a commercial differential isolation medium.144But 
the  presence of intracellular  β  glucosidase activity in  C.dubliniensis is  the 
only phenotypic difference that is found with high consistency.
CANDIDA SPECIES - THE PATHOGEN 
 Several  Candida species  most  notably  C.albicans is  an  ubiquitous 
human commensal,  residing  in  the  GIT  or  they  are  found  in  the  everyday 
human environment. They become pathogens in situations in which the host’s 
resistance to infection is lowered locally or systemically. In such circumstances 
Candida spp.  are  capable  of  causing  disease  in  virtually  every  location  of 
human body.
Candida infections are commonly encountered in medical practice and 
changes in the way in which patients become susceptible to Candida (eg.more 
therapeutic immunosuppressive treatment, spread of HIV infection) have led to 
changes in the epidemiology and clinical presentation of the infection and to a 
steady rise in their incidence over the last 40 years.
Seven  species  in  the  genus  Candida are  well  known  opportunistic 
human  pathogens  and  many  others  have  been  described  as  pathogens  in 
individual case reports or short case series.58
 Species commonly implicated in human infections are,
 C.albicans 
 C.glabrata
 C.guilliermondii
C.krusei 
 C.lusitaniae
 C.parapsilosis
 C.tropicalis.
EPIDEMIOLOGY AND PATHOGENISIS
 C.albicans, the species most often associated with human disease has 
been recovered from many diverse sources apart from vertebrates including the 
atmosphere, fresh water, seawater and soil. It is an occasional contaminant of 
foodstuffs  and  can  be  recovered  from fomites,  particularly  items  that  have 
contacted humans directly such as clothing, bedding and tooth brushes.
 Estimates of the prevalence of Candida spp. as human commensals vary 
considerably according to the nature of the site, the type of person sampled and 
the method of sampling adopted. Many studies of Candida carriage in healthy 
subjects  indicate  an  average  prevalence  of  25-50%  in  the  mouth,96with 
C.albicans- the predominant species found in 70-80% of cases. In hospitalized 
patients  the  oral  carriage  rates  are  higher,  with  yeast-positive  cultures 
obtainable  from 50% -  70% of  subjects  sampled.  The prevalence  of  yeasts 
detectable in culture is generally lower in other common clinical samples such 
as feces and vaginal swabs.
  It seems likely that virtually 100% of humans may carry one or more 
Candida spp. in deeper intestinal sites (from duodenum to the colon) and that 
the number of yeasts carried at any point in the GIT often increases to levels 
that become detectable in the mouth and feces in illness or other circumstances 
in which the host’s microbial suppression mechanisms are compromised. 
 The  half  life  of  Candida spp.  on  the  skin  of  hands  has  been 
experimentally determined as a matter of only minutes. However the capability 
of the yeasts to pass from hand to hand and to inanimate  objects has been 
confirmed,116 and the extended survival  of the yeasts on inanimate objects in 
these  experiments  tend  to  confirm  the  presumption  that  Candida  spp.  are 
transmitted to  inanimate sources from humans and animals. 
VIRULENCE FACTORS
 The state of the host is of primary importance in determining Candida 
pathogenicity.  Infact,  Candida spp.  are  considered  opportunistic  pathogens 
because they are usually benign colonizers of mucosal surfaces and because 
there  must  be  a  breakdown of  mucosal  surfaces  or  in  the  host  defense for 
diseases  to  occur.  However,  there  are  factors  associated  with  the  organism 
rather than the host that contribute to its ability to cause disease and explained 
the differences among species in their pathogenicity.
 Adherence of  Candida spp.  to  a  wide  range  of  tissue  types  and 
inanimate surfaces is essential  in the early stages of colonization and tissue 
invasion. Germinated C.albicans cells adhere to host tissue more readily than 
do yeast phase cells.36
 Although the data on the yeast hyphal dimorphism status of  Candida 
spp.  is  still  inconclusive, dimorphism may  have  some  role  as  a  virulence 
factor.  Some  information  suggests  that  dimorphism  is  important  (but  not 
essential) in causing disease.148 Hyphae of C.albicans have a sense of touch so 
that they grow along grooves and through pores  (thigmotropism). This may 
aid infiltration of epithelial surfaces during tissue invasion.
Davis  and  Denning30 have  shown  hyphae  longer  than  200  µm  are 
poorly phagocytosed and not readily killed by leukocytes.
  The hydrophobicity of the cell surface of C.albicans plays an important 
role  in  the  adhesion  of  organism  to  eukaryotic  cells  and  inert  surfaces. 
Blastoconidia  are  hydrophilic,  but  germ  tube  formation  is  associated  with 
significant rise in cell surface hydrophobicity.131
 The mannans also contribute to the virulence of  C.albicans mainly by 
two mechanisms. They affect yeast cell surface hydrophobicity and suppress 
the immune response by mechanisms not yet completely understood.92
 Enzyme production is also an important virulence factor. The aspartyl 
proteinases produce  non  specific  proteolysis  of  host  protein  involved  in 
defenses  against  infection allowing entry  of  yeast  beyond connective  tissue 
barriers  (C.albicans,  C.dubliniensis,  C.guillermondi,  C.parapsilosis  and  
C.tropicalis). 145
 Phospholipases are produced by C.albicans and in less quantity by non 
albicans spp.(C.dubliniensis, C.glabrata, C.krusei, C.lusitaniae, C.parapsilosis  
and C.tropicalis).
 The  phenotype  switching phenomenon  (the  formation  of  differently 
appearing  colony  types,  particularly  those  showing  discontinuous  fringe 
formation, when cultured on specific synthetic media) may be associated with 
the relative virulence of the species.197It contribute to virulence of  C.albicans 
by  facilitating  its  ability  to  survive,  invade  tissues  and  escape  from  host 
defenses.
 On the  other  end,  neutrophils  themselves  can augment  the  switching 
process towards more susceptible strains. 
 Another  potential  virulence  factor  that  is  still  under  study  is  the 
resistance to thrombin - induced platelet microbicidal protein.172
 Resistance to azoles also contributes to virulence of the organism.
HOST FACTORS
Local tissue damage
Because  C.albicans is  a  culturally  weak pathogen,  any form of local 
tissue  damage  is  likely  to  be  important  in  the  pathogenesis  of  candidiasis. 
Experimental  removal  of  stratum  corneum  facilitates  the  establishment  of 
cutaneous candidiasis.83On the skin, maceration is of fundamental importance 
and  in  experimental  candidiasis;  high  moisture levels  usually  provided  by 
occlusion are a prerequisite.32
Iron
In the anemia of leukemia and chronic infections, levels of both  iron 
and  unsaturated transferrin are  low,  explaining  the  susceptibility  to 
candidiasis in these groups. Higgs & Wells63 showed that some cases of chronic 
mucocutaneous candidiasis had iron deficiency. With iron replacement therapy 
their resistance to Candida infection increased. 
Endocrine factors
In diabetes and Cushing syndrome, the mechanism seems to be a direct 
suppression  of  immune  mechanism,  especially  T  cell  function.  In  addition, 
Addison’s disease, hypoparathyroidism and hypothyroidism have been found 
to occur in association with some cases of chronic mucocutaneous candidiasis, 
in the so-called Candida endocrinopathy syndrome.
In many of these patients definite abnormalities of immune factors76 are 
demonstrable which alone are sufficient to explain the increased susceptibility.
Immunological Factors 
In  the  defence  against  Candida infection,  both  superficial  and  deep 
seated,  cell  mediated  immunity  (CMI)  is  of  paramount  importance  coupled 
with  normal  phagocytosis and  killing  by  polymorphs  &  macrophages.77 
Circulating  humoral  antibodies may  have  some  role51 and  the  role  of 
candidiasis is higher in those with  low salivary IgA levels.25 While systemic 
corticosteroids act to increase the susceptibility to candidiasis by diminishing 
immune functions, there is evidence that an inflammatory response to Candida 
can be suppressed by  topical steroids.122The susceptibility of the elderly and 
of the seriously ill, especially those with leukemia, reticulosis, carcinomatosis 
and HIV infection probably lies in large measure, in the depression of CMI.   
Racial Factor 
The severity of inflammatory response in the American Negroes is 
significantly less than that of the American white.122 This may be interpreted as 
showing increased resistance in the black skin.
ROUTES OF TRANSMISSION OF CANDIDA SPECIES
 Endogenous transmission   
The predominant source of infection in all types of diseases caused by 
Candida spp. is the patient himself or herself. The necessary requirement for 
invasive disease is a  lowering of a host antiCandida barrier. Transmission 
from GIT to the blood stream requires prior overgrowth of the number of yeast 
in  their  commensal  habitat73and  is  favoured  by  loss  of  integrity of  GIT 
mucosa.100 
Exogenous transmission 
Out  breaks  of  Candida spp.  infection  resulting  from  contaminated 
materials have been described. Such routes seem to be of significance only in 
specialized, relatively closed settings such as  burns, geriatric,  hematology, 
intensive care and transplantation units and also the newborns. The hands of 
hospital  personnel  may be a potential  reservoir.  Carriage rate  is  as  high as 
58%.154 
DISEASES SPECTRUM
 The forms of disease most commonly caused by Candida spp. involve 
the female genitalia, the skin and nails, and the oral cavity, sometimes with 
concomitant esophageal invasion. Candida infections of deep tissues are almost 
always,  the  result  of  hematogenous  spread  of  Candida organism  from  an 
endogenous or  less  often an exogenous site.  In  immunosuppressed patients, 
particularly  with  severe  neutropenia candidemia  can  result  in  widely 
disseminated disease usually with a fatal outcome if untreated.
REVIEW OF LITERATURE
DEFINITION
Candidiasis is a primary or secondary infection involving a member of 
the genus Candida. Because of its rapid ability to colonize and take advantage 
of  many  types  of  host  alterations,  the  clinical  manifestations  of  candida 
infection are protean, ranging from acute, subacute and chronic to episodic. 
(Rippon JW: Medical Mycology 3rd edition pg.486)134
Superficial  infections  of  the  mucous  membranes  and  skin  are 
numerically most important but more serious involvement of internal organs as 
in  septicemia,  endocarditis  and  meningitis  can  also  occur.  (Text  Book  of 
Dermatology- Rook 4th Edition, pg 946)127 
HISTORY
The clinical manifestations of candidiasis have been recognized since 
ancient times and were discussed in the writings of Hippocrates,64Galen48 and 
Pepy’s.165 In 1839, Langenbeck 74 described the organism in a lesion of thrush.
 Berg  in  184113and  Bennet14in  1844  conclusively  demonstrated  the  fungal 
biology of thrush.
Until the genus Candida was defined by Berkhout in 1923, a confusing 
taxonomy ensued. Initially classified as Sporotrichum by David Gruby, 53it was 
placed in the genus Oidium (egg shaped, oval yeast cell) by Robin128 in 1847. 
Later  it  was  confused with  another  fungus  isolated  from rotting  vegetation 
(Monilia  candida)  by  Plaut  (1887)109and  was  renamed Monilia  albicians  by 
Zopf in 1890.173The dimorphic nature of the fungus was noted by Gravitz in 
187754& Audrey in 1887.9 In 1853 Robin first described systemic candidiasis. 
Efforts to speciate yeasts placed in this genus were forged by Martin in 1937.
 C.albicans is antigenically divided into two groups, A which it shares 
with C.tropicalis and B which is shared by C.stellatoidea.157Nucleic acid base 
composition  studies  (G-C  ratios)  indicate  that  C.albicans,  C.tropicalis, 
C.clausenii and  C.stellatoidea are  related.152However,  by  DNA  homology 
studies, C.albicans has close relationship to C.clausenii and C.stellatoidea but 
not C.tropicalis.153
           The importance of candidiasis as an opportunistic infection was just 
appreciated in  the  post  antibiotic  era  of  the  1940s when an increase  in  the 
number of candidal infection was noted.
CANDIDA ECOLOGY AND THE COMMENSAL / PARASITE ROLE 
Candida as normal flora
In a prospective study of skin colonization, Henney et al.,61 isolated 69 
species of filamentous fungi over a 175-day period, but 71% were isolated not 
more  than  twice.  In  contrast,  many  Blastomycetes  (yeast,  yeast  like  fungi) 
constitute a resident population of the normal flora of skin surfaces, buccal 
mucosa, the intestinal tract and vaginal mucosa. The species involved and the 
members  present  vary  with  the  body  surfaces  but  make  up  a  balanced 
population in a particular ecological niche on the normal healthy individual. 
Oral carriage
            Candida albicans is a normal inhabitant of the alimentary tract and the 
mucocutaneous regions. (Marples, M.J. The Ecology of the Human Skin)  84 
It is regularly present in small numbers in the mouths of normal healthy adults. 
Poor oral hygiene or even small amounts of antibiotics promote an increase in 
the number of organisms, though usually without untoward results.
Odds  et al.,98in his review concludes that  C.albicans  carriage is about 
10% in the mouth of normal subjects.  Surveys of  the oral  flora  of hospital 
patients always tend to give higher figures.  Odds suggests figures of nearly 
24% for  yeast  carriage  and  just  under  15% for  C.albicans on  the  basis  of 
published studies.  
Cohen  et al., 28studied that in extensive cases the patches may extend 
into the trachea, upper bronchi and even into the esophagus. Because the mouth 
and  rectum  are  easily  accessible  for  swabbing,  gut  carriage  of  Candida  is 
generally  considered  in  these  terms,  but  of  course  there  is  considerable 
evidence that the yeast colonizes the gastrointestinal tract from end to end, the 
relative densities being partly dependent on the transient times through the gut.
It is clear from the experiments of Krause et al.,73that the swallowing of 
massive quantity of Candida organisms will result in the transfer of these yeasts 
rapidly through the gut wall into the circulation, presumably via portal vein and 
the liver.                                     
            Sievers I  et al.,147studied that yeasts isolated from the mouth are 
predominantly  C.albicans (75%) followed by  C.tropicalis (8%)  C.krusei (3-
6%) and C.glabrata (2-6%).
Carmo-sousa L. et al.,  23 studied that in swabs from the anorectal area 
or feces, 50% of the isolates were  C.albicans and upto 20% were  C.glabrata 
and C.tropicalis. 
Odds  FC  et  al.,98 studied  that  C.tropicalis and  C.albicans are  not 
regularly  found  on  normal  skin  but  can  be  recovered  from  the  anogenital 
region, the area around the mouth and the fingers.
Any  damage  to  skin  or  mucous  membrane  or  environmental  change 
leads to rapid colonization. Endocrine balance, the administration of steroids, 
and  other  physiologic  factors  also  influence  the  rapidity  and  extent  of 
C.albicans colonization.
C.albicans can occasionally  be  cultured  from environment  usually  in 
situations  where  heavily  infected  subjects,  human  or  animals  are  located. 
Winner H I  & Hurley R. et al.,166 have isolated  C.albicans from a nursery 
where there was an epidemic of oral thrush  and Clayton Y M &Noble W C27 
isolated from hospital bed linen  and  Friedrich E  & Blashke-Hellmessen45 
from the air  of  dermatology clinics.  Normally,  however,  Candida is  not  air 
borne. 
C.albicans is frequently isolated from thermal baths, 4  heavily utilized 
beaches5,19,146and  occasionally  from  swimming  pools.  It  is  sensitive  to 
chlorination,(105 cells inactivated by 4 ppm Cl at 30 min)68however, will die 
rapidly in sea water.19  C.albicans can survive for fairly long periods in beach 
sand,5dairy products and other kinds of food 129 but not in soil, on plants or in 
the atmosphere.
Candida associated with human disease
Except for neonatal and conjugal infections most cases of candidiasis 
probably  result  from  infection  of  the  host  by  his  own  commensal  yeasts. 
Certainly  isolates  of  C.albicans from  normal  subjects  do  not  differ 
enzymatically from those isolated from lesions of thrush,26,72  though they have 
recently been said to differ antigenically.
C.albicans appears to be the only member of this genus  regularly  able 
to  evoke  fatal  disease in man and  animals.(Mourad  et al.),87,112In animal 
experiments some candida species have been shown to be less virulent than 
C.albicans,166 a finding which confirms well with known clinical experience.
C.stellatoidea and C.tropicalis, though less pathogenic than C.albicans, 
are significantly more virulent than other candida spp. Together C.albicans and 
C.tropicalis account  for  about  80%  of  the  species  isolated  from  medical 
specimens.(Rippon J W  Medical Mycology 3rd edition 1988 pg 532) 136
Stanford et al., (1980)151 studied that of the various species in the genus 
Candida,  C.albicans is  the  most  common cause of  superficial  and systemic 
candidiasis.  Other  Candida  spp.  particularly  C.tropicalis,  C.parapsilosis, 
C.kefyr,  C.guilliermondii,  C.krusei and  C.glabrata also  account  for  some 
infections. But the severity of the host’s debilitation must be greater to allow 
these less virulent organisms to invade. 
             Wingard et al.,170 in a review of 1591 cases of candidal infections 
published in 37 reports between 1952 and 1992, found that non- albicans spp. 
were the causative agents in 46% of systemic infections. C.tropicalis accounted 
for  25%  of  the  infections,  C.glabrata for  8%,  C.parapsilosis for  7%,and 
C.krusei for 4%. From these reports, patients with malignancies (leukemias) 
were more likely to be infected with C.albicans or C.tropicalis.
Hazen57 in his extensive review of new and emerging yeast pathogens 
states that there is increase in non-albicans spp., C.parapsilosis and C.glabrata 
(bloodcultures), C.krusei, C.guilliermondii, C.lipolytica, and C.kefyr.
Redding SW et al.,123observed that particularly C.glabrata, has emerged 
as  causative  agent  of  oropharngeal  candidiasis  (OPC)  among 
immunocompromised patients. 
C.dubliniensis is  a  recently described species that has been shown to 
cause oropharyngeal candidiasis in patients with HIV. In addition to being a 
significant cause of candidiasis, C.dubliniensis  was found to be easily induced 
to develop resistance to fluconazole in vitro, a phenomenon which may have 
resulted in its emergence. C.dubliniensis produce higher levels of proteinase, 
are more adherent to buccal epithelial cells and the oral anaerobic bacterium 
Fusobacterium nucleatum, and reveal major ultra structural differences in the 
cell  walls  than  C.albicans.  These  factors  play  an  important  role  in  the 
colonization ability of C.dubliniensis in the oral cavity.  Redding SW,  Bailey 
CW et  al.,124 identified a  mixed infection  of  C.dubliniensis and  C.albicans 
OPC, in patients undergoing head and neck radiation for oral cancer. 
Predisposing factors 
        Age and sex distribution as well as clinical manifestations of candidiasis  
are  markedly  affected  by  varying  predisposing  factors  and  the  underlying 
disease of the patient. Normal equilibrium between Candida and the normal 
host may be sufficiently upset to lead a pathological state in:
1. Extreme  youth:  During  the  normal  process  of  establishing  a 
resident flora, the restricting factors for Candida may be absent, 
and a clinical condition is produced.
2. Physiologic  changes:  pregnancy  &  diabetes(increased 
carbohydrate content).
3. Prolonged administration of antibiotics.
4. General disability and the constitutionally inadequate patient: 
Debility  includes  slight  avitaminosis  of  the  aged,  diabetes  and  its 
cutaneous  candidiasis,  candidal  vegetations  of  diseased  heart  valves, 
pulmonary or generalized systemic candidiasis as sequelae to chronic disease 
or as a    terminal event in the various neoplasias. 
Constitutionally inadequate patients include those with various immune 
defects associated with abnormal leukocytic functions.
    5. Iatrogenic & barrier break candidiasis: 
Iatrogenic can result from a wide variety of insults -indwelling catheters, 
hyperalimentation, or injection of material into the skin, muscle, or   circulatory 
or central nervous system.
Also accidental barrier breaks such as trauma, burns, or gun or knife 
wounds.
Ecological factors
The  effects  of  ecological  pressures  from  other  organisms  are  of 
considerable  importance.  Both  in  the  gut  and  on  the  skin,  removal  of 
competitive organisms usually, bacteria lead to an increase in yeast numbers, 
an important prerequisite for the shift to pathogenic role.
In the newborn, however, before an oral ecology is established, even a 
few  organisms  presage  clinical  thrush.  In  the  new  born,  incidence  of  oral 
candidiasis rates as high as18 % has been recorded, but the average appears to 
be 4 %. (Rippon pg 491). 135 
Work  on  the  competition  between  candida  and  bacteria  in  saliva 
suggests that the crucial factor is the amount of available glucose  10 and that if 
this is elevated and plentiful, as in diabetes, the bacterial flora will not inhibit 
the yeast.72Mechanisms other than nutrition depletion may possibly apply.69
Host factors
It has long been recognized that the very old, the very young and the 
very ill are susceptible to oral thrush.165 Food debris likely to be present in the 
mouth of the severely ill patient with inadequate oral hygiene should not be 
ignored and may be as significant as diabetic saliva. In Sjogrens syndrome, 
Candida  carriage  and probable  susceptibility  to  candidiasis  are  high,  a  fact 
attributed to low salivary flow rates.85
Candida infection of oropharynx
Oral Candida infections occur predominantly in patient population, who 
suffer some kind of systemic or local immunosuppression or who are exposed 
to other factors that favour the overgrowth and invasiveness of this fungus.
Therefore  Candida  oral  infections  are  mainly  seen  in  immunosuppressed 
individuals such as, 
Newborns with asphyxia 55 
Persons with diabetes130  
Patients infected with HIV75 
Patients receiving corticosteroid or cytotoxic chemotherapy particularly 
for hematologic malignancies.33
Patients undergoing maxillo facial radiotherapy 37 
Recipients of organ or stem cell transplantation 33
Persons exposed to prolonged antibiotic 130,62 or inhaled steroids 159 
Those who wear dentures 62
Clinical Syndromes of Oral candidiasis
1).  Acute  pseudomembranous  candidiasis  –“oral  thrush”  (Rippon  JW, 
Medical Mycology 3rd edition pg 492)137
This  is  the  commonest  form  of  disease  produced  by  over  growth 
(colonization)  of  C.albicans.The  characteristic  sign  of  this  condition  is  a 
sharply defined patch of creamy white to gray pseudomembrane that covers the 
tongue,  soft  palate,  buccal  mucosa,  and  other  oral  surfaces.  It  is  closely 
adherent to the underlying mucosa, and its removal reveals a red, oozing base. 
They often crumble and have the appearance of milk curds. Extension to the 
pharynx or the esophagus may occur. 
Acute atrophic oral candidiasis78 (antibiotic dermatitis) 
May occur de novo or after sloughing of the pseudomembrane of the 
thrush. It is commonly associated with broad spectrum antibiotic therapy and 
the use of topical, inhaled or systemic corticosteroids.106,115
Chronic atrophic candidiasis 20,21(denture stomatitis) 
Affects  one  in  four  denture  wearers  normally  confined  to  the  upper 
denture bearing area. More common in females and 60% of those are older than 
65 years of age. 
Chronic hyperplastic candidiasis 21
Very  persistent  firm,  irregular,  white  plaques  occur  in  the  mouth 
commonly on the cheek or the tongue, which cannot be easily removed. Occurs 
in AIDS and chronic mucocutaneous candidiasis syndrome. Though it may go 
on to malignant change,40 it may eventually clear with prolonged anticandida 
therapy.
Median rhomboid glossitis 29
Characterized by diamond shape area on the dorsum of the tongue with 
loss of papilla. Occurs as an acquired condition. 
Angular cheilitis
Soreness of the angles of the mouth extending to the facial skin.
Candida cheilitis
The center of lip is usually involved. 
Oral candidiasis in cancer patients 
 Oropharyngeal candidiasis is a common infection in patients receiving 
cancer therapies with an incidence of 5%. Thrush can be present in 28% to 
38% of cancer patients undergoing therapy with corticosteroids or cytotoxic 
agents. Samonis et al., & Yeo E et al. 143,171
Oral mucosal colonization (up to 93%) and infection (ranging from 17 to 
29%)  with  Candida are  particularly common in  patients  receiving  radiation 
therapy for head and neck cancer. Compromised salivary function secondary to 
destruction  of  glandular  tissue  by  radiation  is  thought  to  be  a  major  factor 
leading to  Candida infection. This infection is marked by oral pain and / or 
burning  and  can  lead  to significant  patient  morbidity.  Spencer  W 
Redding et  al.149
When salivary glands are included in the field of radiation, xerostomia 
occurs.  Radiotherapy-induced  hyposalivation  encourages  oral  candidal 
colonization that often leads to oral/pharyngeal candidiasis. 17.4% developed 
clinical  candidiasis  during  radiotherapy  in  the  study  by  Ramirez- 
Amador V et  al.114 
Irradiation mucositis is defined as an inflammatory-like process of the 
oropharyngeal mucosa following therapeutic irradiation of patients who have 
head and neck cancer. A scoring method based only on local mucositis signs 
includes  white  discoloration,  erythema,  pseudomembranes  and  ulceration. 
Mucositis  of  the  oral  cavity  in  15 irradiated head and neck cancer  patients 
when studied  by  Spijkervet FK et al.,150 displayed an S-curve reflecting a 
symptomless first irradiation week, followed by a rapid and steady increase of 
white  discoloration,  erythema and pseudomembranes  during  the  second and 
third week. Oral candidiasis, generalized symptoms such as weight loss and the 
highest mucositis scores were seen after 3 weeks irradiation.  
The presence and use of oral prostheses, alcoholism and smoking as risk 
factors for oral colonization by Candida during radiation therapy were observed 
by Epstein J B et  al.38 
Patterson T F et al,101  suggest a greater likelihood of developing OPC 
caused  by  Non-Albicans  Yeasts  in  patients  receiving  concomitant 
chemotherapy and external beam radiotherapy(EBRT). 
Patients  receiving  radiation  for  head  and  neck  cancer  evaluated  and 
cultured weekly for candidiasis,  showed mixed colonization with  C.albicans 
and C.dubliniensis, by BAILEY C W et al. 117
Severe  neutropenia  is  considered  the  most  significant  predisposing 
factor for life threatening candida infections. In a recent study by Maksymiuk 
aw et al., major candida infections occurred in 84% of leukemia patients who 
had less than 1000 cells/mm3 for 13 days.82 In the setting of neutropenia, there 
is  a  high risk of oral  candidiasis  evolving to systemic infections.  This  may 
occur in several ways
1. Direct invasion of the oral mucosa through ulcerations.
2. Extension  of  orophayageal  infection  into  the  oesophagus  producing 
oesophageal ulceration, fungemia and dissemination.
3. Extension into GIT.
4. Aspiration of oral secretions causing pneumonia.16
Oral candidiasis and AIDS
Klein RS  et al.,  studied that  oral  candidiasis is  a common early and 
often initial manifestation of infection with HIV. 71
Unexplained oral candidiasis in previously healthy adults at high risk for 
AIDS predicts the onset of other serious opportunistic infections or Kaposi’s 
sarcoma. Over 50% of the time the diagnosis of oral candidiasis preceded the 
features  of  AIDS  by  a  mean  time  of  3months.The  CD4/CD8    ratio  was 
significantly depressed. The incidence of oral candidiasis in persons with AIDS 
approaches 100% particularly when CD4 counts are below 200/µl.52
          Mocroft A et al., studied that oesophageal candidiasis accounts for upto 
15% of the AIDS defying illnesses. 88 Porro G B , Parente F et al.,  noted upto 
30%  of  patients  with  candida   oesophagitis  did  not  have  oral  thrush.111 
Similarly  only 64-88% of patients with thrush have concomitant oesophageal 
candidiasis. 
The wide spread use of the antifungal agent fluconazole for therapy and 
prophylaxis  in  HIV infected  patients  have  resulted  in  fluconazole  resistant 
strains of C.albicans was studied by Rex J H et al., 121 The increased frequency 
of non albicans strains in the oral mucosa especially among patients with late 
stage AIDS and those who receive radiotherapy for malignancy of head & neck 
was observed by Canuto  M D M et al.,22
Oral candidiasis in diabetics
High glucose level in urine,  in saliva,  in general  tissue fluids and in 
sweat may make the diabetics more susceptible to candidiasis.72  In a group of 
diabetics with symptoms of oral candidiasis and denture stomatitis, C.albicans 
was identified in 57.1% of cases. In patients with urinary tract infections the 
presence of C.albicans was shown in 67% of cases. Dorko E et al.31 
In  non-diabetics  exposed  in  their  occupations  to  high  carbohydrate 
levels,  (eg.)  bakers  an  increased  level  of  candida  infection  in  the  form  of 
chronic paronychia is  recognized clinically.   It  has been suggested that  low 
squalene levels and possibly reduced bound carbohydrate are factors leading to 
candidiasis of skin fold. 49
Among persons with diabetes, local factors such as smoking, alcoholism 
and the presence of dentures additionally promote candidal colonization of the 
mouth.158The incidence in debilitated elderly patients has been estimated to be 
10%.
Disseminated candidiasis 
According to Bodey G P, Fainstein V et al.,16, 18 the overall incidence of 
candidiasis has increased persistently world wide during the second half of 20 th 
century. This is due to an increase in the large immunocompromised population 
resulting  from  their  underlying  disease,  (malignancy,  AIDS)  or  aggressive 
treatment with potent immunosuppressive drugs and patients who are sustained 
for  long  periods  by  means  of  intensive,  care  increasing  the  size  of  the 
population at risk for candidemia. 
  C.albicans is still the predominant species causing more than 50% of 
the cases of candida infection and the fourth leading cause of blood stream 
infection.103  
Risk factors for dissemination
Gastro intestinal colonization with candida spp. seems to be necessary 
for  infection.  These factors  contribute  to  the  development  of  hematogenous 
candidiasis through one or all of the following mechanisms.
1. Increased colonization by candida spp.
a. Endogenous: prolonged  and  multiple  antibiotic  treatment 
suppress  the  endogenous  microflora56  and  enhance  the 
overgrowth  of  endogenous  candida  spp  at  mucosal  sites, 
(especially gut)
b. Exogenous:  prolonged  hospital  stay  increases  the  risk  of 
acquisition of candida strains present in the hospital environment. 
(eg.  contaminated  equipment,  health  care  worker’s  hands  and 
colonized patients)
2. Alterations in the integrity  of GI mucosa leading to increased fungal 
translocation, by direct vascular invasion when there is mucosal trauma 
secondary  to  TPN,  malnutrition,  surgery,  chemotherapy  induced 
mucositis, 15,95severe burns and graft-versus-host disease increase the risk 
of candidemia.
3. Immunosuppression:  Local  (increased  risk  of  candida  species 
multiplication or translocation or both) or Systemic (increased risk of 
hematogenous disease)
Morbidity & Mortality
The mortality  attributable  to  hematogenous  candidiasis  is  high.163The 
crude mortality rate ranges from 26% - 57%.46,86,93,94  Therefore the speed with 
which antifungal treatment is initiated even if treatment is given empirically 
can be decisive in a patients survival.  Candidemia is also associated with the 
30 day prolongation of hospital stay.164  A recent prospective study found that 
candida spp.  was the only microorganism that  independently influenced the 
outcome of bloodstream infections being associated with mortality rates higher 
than  those  of  other  pathogens.95 The  most  important  prognostic  factors  for 
hematogenous candidiasis are old age, poor performance states, (APACHE –
acute physiology and chronic health evaluation) presence and persistence of 
neutropenia and extensive organ involvement with candidiasis
Diagnosis
 In  addition  to  clinical  evaluation  of  the  patient,  direct  microscopic 
examination of the specimen for the presence of yeast and isolation of yeast in 
culture  is  needed  for  definite  proof  of  infection. (Rippon  J  W  Medical 
mycology pg 516)138 
Direct examination (Grams stain)
In  oropharyngeal  candidiasis  (OPC),  diagnosis  can  be  made  by 
observing  typical  budding  yeasts  (2-6µm× 3-9µm)  with  hyphae  or 
pseudohyphae (elongated filamentous cells connected in sausage like manner). 
The mere finding of yeasts in such materials is of no diagnostic importance. 
However,  mycelial  form  of  organisms  usually  connotes  an  established 
colonization of the involved area. (Ripon. J W. Medical Mycology 3rd edition 
pg 516) 138
Growth on Sabouraud’s dextrose agar (SDA)
C.albicans grows readily on bacterial media, but Sabouraud’s dextrose 
agar (pH 5.6) with added antibiotics is usually recommended for isolation. 
All clinical specimens should be freshly taken and cultured on suitable 
media as soon as possible. Cultures are incubated at room temperature (25°c to 
27°c) or 35˚c and examined periodically for growth of yeast. Whitish, mucoid 
colonies grow within 2 to 5 days. 
The urease test should also be performed from the isolated colonies on 
SDA to differentiate the yeast Cryptococcus.
Rapid identification of Candida albicans
As  C.albicans is  the  most  important  yeast  in  human  disease,  many 
procedures  have  been  proposed  for  its  rapid  identification.  C.albicans is 
differentiated from other non-albicans species by the formation of germ tube; 
the production of chlamydospores on semi starvation medias like Corn meal 
agar;  absence  of  chlamydospores  on  Sunflower  Seed  Husk  Agar  and 
development of opalescence within three days on the Tween80 medium.
Germ tube test (Reynolds-Braude phenomenon) 
One of the most reliable methods is incubation of the unknown yeast in 
0.5 ml of pooled human serum at 37oC for two hours. (Rippon.JW Medical 
mycology  pg  517)139Filamentous  extension  from  the  yeast  cell,  with  no 
constriction at the point of origin is considered positive. Germ tube represents 
the  true  hyphae  whereas  the  pseudohyphae  are  derived  from  the  budding 
process of blastoconidia and failure of cells to get separated from the mother 
cell. C.albicans, C.stellatoidea and C.dubliniensis produce germ tube.
Morphology on Cornmeal agar-Tween 80 medium
Transition of growth to the mycelial stage in the absence of fermentable 
carbohydrate is a characteristic of the genus Candida. Corn meal agar is an 
enrichment medium developed by Hazen and Reed for use in cultivation of 
fungi.  On  the  Corn  meal  agar  with  Tween  80,  the  commonly  encountered 
human  pathogenic  and  saprophytic  species  produce  rather  characteristic 
mycelial  forms  and  structures.  Other  members  of  the  genus  candida, 
particularly  C.glabrata do  not  form  mycelium  on  the  corn  meal  medium. 
(Rippon: 518-525)140
Walker and Huppert, in 1960, found that the addition of Tween 80 to 
corn  meal  agar  resulted  in  rapid  and  abundant  chlamydospore  formation. 
Among  the  yeasts  encountered  in  humans,  generally  only  C.albicans and 
C.dubliniensis produce chlamydospores on semi starvation medium like corn 
meal agar. Occasional strains of C.stellatoidea and C.tropicalis produce these 
conidia.  (Rippon.JW Medical mycology pg 517) 139
Sunflower Seed Husk Agar medium (Khan ZU et al., 70& Pinjon E et al.,107)
The Sunflower (Helianthus annuus) Seed Husk agar medium has been 
developed and evaluated for differentiation of  C.dubliniensis  from C.albicans 
on the basis of colony morphology and chlamydospore production.
C.dubliniensis isolates produce rough colonies with hyphal fringes and 
abundant  chlamydospores  whereas  C.albicans isolates  produce  smooth 
colonies with no evidence of chlamydospore production. 
Tween 80 opacity test  (Rudek W132 &  Malcolm Slifkin.80)
Many of the pathogenic Candida spp. secrete lipolytic enzymes such as 
esterases  and  phospholipases.50The  esterase  activities  of  these  yeasts  are 
demonstrated  with  the  application  of  Tween  80  opacity  medium.  The 
hydrolysis  of  the  Tween  opacity  medium  is  associated  with  the  lipolytic 
enzymes produced by the respective Candida spp. Liberated fatty acids bind 
with  the  calcium  incorporated  into  the  medium.  This  calcium  complex  is 
visible as insoluble crystals around the inoculation site.
All strains of C.albicans and C.tropicalis produce a halo response within 
2-3 days of inoculation and negative response for C.dubliniensis.The isolates of 
C.guilliermondii  and C.rugosa  yield a halo at 3-9days-post inoculation. The 
Tween  80  opacity  test  permits  the  clear  differentiation  of  the  strains  of 
C.albicans from the strains of C.dubliniensis within 3 days of incubation on the 
Tween 80 medium.  It  appears  to  be  a  useful  adjunct  that  complements  the 
standard morphologic and physiological tests that are used to identify various 
spp.  of  Candida.  The  test  medium  is  simple,  economical  and  is  easy  to 
interpret. 
CHROM agar Candida (CAC)
The new CAC medium aids in the identification of the Candida spp. The 
yeast  produces enzymes that  react  with chromogenic substrates in the CAC 
medium producing colonies of different colours. These enzymes are specific, 
allowing some yeasts to be identified to the species level by their colour and 
colony  characteristics.  CHROMagarCandida  uses  a  chromogenic 
β-glucosaminidase substrate,  which is metabolized to give green colonies of 
C.albicans (light green),  C.dubliniensis (dark green),  blue green colonies of 
C.tropicalis, and fuzzy rose-colored or white colonies of C.krusei. CAC can be 
used as the sole primary medium for  fungal cultures of  specimen in which 
yeasts are the main fungus sought. When compared to other media commonly 
used  CAC is  superior  in  the  primary  isolation  of  yeasts  and in  identifying 
mixed colonies of yeasts.
CHROMagar  Candida  (CAC)  is  increasingly  being  reported  as  a 
medium  used  to  differentiate  C.albicans from  non-albicans Candida  spp.
(NAC).  Rapid  identification  of  NAC  can  assist  the  clinician  in  selecting 
appropriate antifungal therapy. Some reports have proposed that CAC can also 
reliably identify C.dubliniensis and C.glabrata. Hospenthal DR et al.66
CHROMagar candida usually allows atleast the effective differentiation 
of  C.albicans from other yeasts (C.tropicalis and  C.krusei) based on one or 
more of its unique enzyme activities. CHROMagar candida is an ideal medium 
for Candida isolation because it has revealed mixtures of candida spp.in many 
types of clinical specimens more often than would have been expected. For 
laboratories unable to use this isolation medium for economic reasons, it is still 
possible to take advantage of it  to look for mixed yeast populations only in 
positive cultures obtained with a cheaper medium. 
CAC was noted to recover more yeast isolates than RM (routine media) 
when mixed cultures were detected. Murray CK et al. 90
Ribot,  W  R  Kirkpatrick  et  al.,126 suggests  a  higher  likelihood  of 
developing OPC in patients receiving concomitant CRT. Chromogenic media is 
helpful  to  screen  for  relatively,  commonly  occurring  non-  albicans yeasts 
causing OPC in head & neck cancer patients.
Confirmation of Candida species
Carbohydrate assimilation test 
 If there is difficulty in deriving a presumptive identification from the 
growth patterns on Cornmeal agar, carbohydrate fermentation or assimilation 
tests  may  be  required  for  final  species  identification.  Assimilation  test  is 
preferred  as  the  fermentation  tests  give  more  false  positive  results  due  to 
endogenous carbohydrates.  (Elmer Koneman, Color Atlas and Text Book of 
Diagnostic Microbiology, 5th edition, 1043)34 
ANTIFUNGAL SUSCEPTBIILITY 
Blood stream infections caused by C.albicans and C.tropicalis are more 
likely to occur among patients who do not receive fluconazole therapy.1The use 
of azoles in prophylactic antifungal treatments may increase the likelihood of 
infection  by  C.glabrata and  C.kursei 168 but  doesn’t  seem to  influence  the 
likelihood of infections by C.parapsilosis. 
Oropharyngeal  candidiasis  with  non-albicans spp.  C.glabrata  and 
C.krusei are being isolated with increased frequency in HIV patients and are 
commonly less susceptible to fluconazole than C.albicans. Also, the presence 
of  non-albicans Candida  was  more  frequently  associated  with  severe 
symptoms. Redding SW et al.118
C.glabrata has  emerged  in  recent  years  as  a  significant  cause  of 
systemic  fungal  infection.  Development  of  resistance  to  fluconazole  by 
C.glabrata is  a  highly  varied  process  involving  multiple  molecular 
mechanisms. Redding S W , Kirkpatrick W R et al.119 
Of note  C.dubliniensis is a novel species that may be misdiagnosed as 
fluconazole resistant C.albicans.113 
Prolonged  antifungal  therapy  will  induce  resistance.  Multiple 
observations have demonstrated that this event is frequent  81 On the other hand, 
it has also been shown that antifungal agents can reduce the rate of relapse and 
colonization.110
For  this  reason,  the  susceptibilities  of  isolates  recovered  from 
compromised  patients  should  be  monitored.  In  order  to  do  this  in  a  cost-
effective way, simple, inexpensive testing procedures are needed, but such tests 
must be accurate and precise.
Recently  the  National  Committee  for  Clinical  Laboratory  Standards 
(NCCLS)  Subcommittee  on  Antifungal  Testing  has  proposed  an  agar  disk 
diffusion  method,  M44-P,  for  testing  of  fluconazole  against  yeasts.  This 
method has been shown to be accurate and precise and correlates well with the 
NCCLS broth microdilution (BMD) MIC method when testing Candida. Zone 
diameter interpretive criteria have been developed along with reference MIC 
correlates for the categories of susceptible (S) (19 mm [≤8 μg/ml]), susceptible
—dose dependent (SDD) (15 to 18 mm [16 to 32 μg/ml]), and resistant (R) 
(≤14 mm [≥64 μg/ml])
Aim
To study the prevalence of oropharyngeal candidiasis  in the immuno 
compromised individuals mainly, patients on radiotherapy, HIV infected and 
the diabetic patients who attended Tirunelveli Medical College Hospital.
Objectives
1. To detect the occurrence of Candida by 
 Grams staining
 Culture on Sabouraud’s Dextrose Agar 
2. To speciate the Candida by
 Germ tube test
 Growth on Cornmeal Agar Tween 80
 Sunflower Seed Husk Agar
 Opalescence on  Tween 80 Medium
 Specific colour on CHROM agar candida
 Morphology on Cornmeal Agar Tween 80
 Carbohydrate  Assimilation  on  Yeast  nitrogen  base 
medium
3. To find out the antifungal susceptibility of the candida isolates 
by the disc diffusion method approved by NCCLS M44 – P 
document.
MATERIALS & METHODS
This prospective study was conducted at Tirunelveli  Medical College 
Hospital for a period of 18 months from January 2005 – June 2006. The study 
group  included  immunocompromised  individuals  –  patients  who  received 
radiotherapy  for  malignancies  of  the  oral  cavity,  patients  attending  the 
Voluntary Counseling and Testing Center (VCTC), and the patients attending 
the diabetic out patient department.
SELECTION OF PATIENTS 
Inclusion criteria
1. Patients who had received external beam radiotherapy (EBRT- 45 Gy 
in15days, 3Gy / day) and developed oral candidiasis.
2. Patients  who  were  proved  HIV  (human  immunodeficiency  virus) 
positive  by  double  ELISA  method  with  clinical  stages  B1,  B2,  B3 
according  to  CDC  classification.  (Symptomatic  and  CD4count 
>500cells/µl(B1), 200-500cells/µl(B2),<200cells/µl) or stage 3 of WHO 
clinical staging.
3. Patients with uncontrolled diabetes for more than a year. 
Exclusion criteria
1. Patients on EBRT (external beam radiotherapy) for oral malignancies 
for <15days without any oral complication.
2. Patients proved HIV positive by double ELISA method but who were 
not in stage 3 of WHO clinical staging.
3. Patients  with  known  history  of  diabetes  for  a  short  period 
(6 months).
A total of 190 immunocompromised individuals were studied and evaluated 
for the occurrence of candidiasis. Speciation & antifungal susceptibility pattern 
of the yeast isolates were done.
SPECIMEN COLLECTION
History was elicited regarding the risk factors like smoking, alcoholism 
and tobacco chewing.
The CD4 cell count was noted in all the HIV infected individuals.
Patients were screened for the presence of white patch on the tongue, 
mucosa of the hard and soft palate, and the buccal cavity. Patients were also 
screened for glossitis of the tongue. 
Two oral swabs were taken from the lesions using sterile Himedia dry 
cotton swab, one for direct smear and the other for culture. 
SPECIMEN PROCESSING
DIRECT EXAMINATION – GRAMS STAIN 
Grams stain was performed on all  the 190 samples and screened for 
budding yeast cells by direct examination.
Smears prepared from the oral swab were fixed, stained and examined 
under oil immersion objectives (100 x). 
Presence of gram positive, oval budding yeast cells (2-4µm), elongated 
filamentous cells,  connected in a sausage like manner (pseudohyphae) or as 
truly septate hyphae were consistent with the morphology of Candida spp. 
CULTURE METHODS
 Species identification relies on isolation of the yeast  in pure culture 
followed by biochemical and physiologic tests.
PRIMARY ISOLATION ON SABOURAUD’S DEXTROSE AGAR (SDA) 
Oral swabs freshly taken using sterile, Himedia dry cotton swab were 
cultured onto Sabouraud’s dextrose agar (pH5.6) containing chloramphenicol 
(50mg/l)  and  gentamicin  (20mg/l)  to  minimize  bacterial  contamination. 
Cycloheximide was not incorporated in isolation media, because it inhibits the 
growth  of  some  species  (C.tropicalis,  C.krusei,  and  C.parapsilosis).  The 
inoculated SDA plates were incubated at 35°C for 48-72 hrs.173 Relatively large, 
butyrous  colonies  were  easy  to  distinguish and isolated colonies  from each 
positive culture were selected and again subcultured to SDA slants for stock 
culture. 
UREASE TEST 
 A portion of  the  colony from SDA (Sabouraud’s  dextrose  agar) was 
inoculated to the surface of a Christensen’s urea   agar slant and incubated at 
37°c for 18-24 hours.

The change in color of the slant to pink is a positive test, differentiating 
the yeast Cryptococcus from Candida, which is urease negative. (Koneman, 
Color Atlas and Diagnostic Microbiology 5th edition pg 1043)34
RAPID IDENTIFICATION OF C.ALBICANS
Since  C.albicans accounts for majority of the Candida infections,  all isolates 
were subjected to the following tests:
 Germ tube test
 Production of chlamydospores on Corn Meal-Tween  80 agar 
 Production of chlamydospores on Sunflower seed husk agar
 Tween-80 opacity test
 CHROMagar Candida 
GERM TUBE TEST (REYNOLDS –BRAUDE PHENOMENON)
Procedure 
A small portion of isolated colony of yeast to be tested was suspended in 
a sterile test tube containing 0.5 ml of pooled human serum and incubated at 
37oC  for  two  hours.  A  drop  of  yeast  serum  suspension  was  placed  on  a 
microscopic slide, overlaid with a coverslip and examined microscopically for 
the  presence  of  germ  tube.  The  test  is  not  valid  if  examined  after  2  hrs. 
(Rippon.JW Medical mycology pg 517)139
Filamentous extension from the yeast cells about ½ the width, and 3-4 
times the length of the cell,  with no constriction at the point of origin was 
considered positive. Germ tube represents the true hyphae. 

CORMEAL AGAR WITH TWEEN 80 
Cornmeal (Himedia) 2gm, agar 15gm and Tween 80 -7ml were added to 
1 liter of distilled water, pH adjusted to 6.2 and autoclaved at 121°c, 15lbs for 
15 mins. Medium was cooled to 45-50°c, poured into sterile Petri dishes and 
allowed to solidify for atleast 30 mins.
Tween 80 (polsorbate-0.02%) was added to corn meal agar to reduce the 
surface tension and enhance the formation of hyphae and blastoconidia. The 
morphology of the blastoconidia, chlamydospores and the ability to produce 
pseudophyphae  helped  in  the  identification  of  the  species.  (Rippon.JW 
Medical mycology pg 517)139
Procedure:
      1.Using an inoculating needle, a visible paste of the organism was obtained.
         The needle was drawn through the agar making two perpendicular lines in
         the shape of an ‘x’.
2. A cover slip was flamed, allowed to cool and placed over the central area 
of the ‘x’ in order to reduce the O2   tension. Reduced O2 tension stimulated 
the chlamydospore production.
3.The plate was sealed with a tape and incubated aerobically at 25-30°c for 
upto 72hours.
4.Inverted  plates  were  examined  microscopically  using  a  low  power 
objective, along the edge of the coverslip for detection of 




chlamydospores.(Koneman, Color Atlas and Diagnostic Microbiology 5th 
edition pg 1043 & Hardy and Hugo diagnostics)34
Interpretation 
C. albicans:   produce compact  clusters  of  blastoconidia  at  regular  intervals 
along pesudohyphae. ( Intercalary or terminal chlamydospores).
C.dubliniensis:  produce  clusters  of  chlamydospores  usually  in  doublets  or 
triplets.
C.tropicalis produce  abundant  pseudomycelium  composed  of  elongated 
blastoconidia widely spaced, in single or small clusters along the hyphae.
C. parapsilosis produce thin, much branching pseudomycelium and verticals of 
few  ovoid  to  elongate  blastoconidia.Thick  pseudomycelium  and  giant  cells 
may be present.
C.krusei produce elongated blastoconidia in tree or crossed match stick like 
arrangements.
C.glabrata produce no pseudomycelium, but only small round yeast cells are 
seen.
C.kefyr produce abundant pseudo mycelium with very elongated blastoconidia, 
lying parallel like logs in a stream. Blastoconidia are not abundant.
SUNFLOWER SEED HUSK AGAR
As per  Khan ZU  et al.,70  & Pinjon E,  et al.,107sunflower (Helianthus 
annuus) seed husk agar medium was prepared and evaluated for 

differentiation  of  C.dubliniensis from  C.albicans on  the  basis  of  colony 
morphology and chlamydospore production. 
The sunflower seeds were purchased from open market and the husk 
was  separated  manually. The  medium  was  prepared  as  follows:  50gram 
sunflower seed husk was pulverized in domestic grinder for 3-4 minutes. The 
pulverized husk was boiled for 30 minutes with 1 liter of distilled water and 
filtered through several layers of gauze. To the husk extract so obtained were 
added 15gram agar and 10 gram glucose. The volume was made up to 1 liter 
and pH adjusted to 5.5 before autoclaving at 121˚c, 15 lbs for 15 minutes. 
Dalmau plate culture 
All the isolates forming germ tubes and chlamydospores on Corn Meal 
Agar–Tween 80 (CMA-T80) were streaked on Sunflower Seed Husk (SSHA) 
Agar for studying the colony morphology and chlamydospore production. With 
a sterile inoculating needle, two streaks, approximately 1.5 cm long, were made 
on the media one centimeter apart without digging into the medium. Only a 
very small quantity of the culture was streaked. After flaming and cooling the 
needle,  an  S-shaped  streak  was  made  across  the  two  streaks  made  earlier.  
Coverslip  (22  ×  22  mm) was  flame sterilized,  cooled  and placed over  the 
streak  marks.  The  plates  were  incubated  at  28°C  and  examined  under 
microscope using low (10x) and high power (40 x) at 24, 48 and 72 h intervals.
 C.dubliniensis isolates produce rough colonies with hyphal fringes and 
abundant  chlamydospores  whereas  C.albicans isolates  produce  smooth 
colonies with no evidence of chlamydospore production.
TWEEN 80 OPACITY TEST
         Plain agar medium was prepared with 10gm peptone, 5gm Nacl, 0.1gm 
CaCl2, 15gm  agar,  and  1000ml  distilled  water.  After  the  medium  was 
autoclaved at 121°c, 15lbs for 15 mins. It was cooled to about 50°c, and 5ml of 
autoclaved Tween 80 was added. The final pH of the medium was adjusted to 
6.8.  The 90 mm petri dishes were filled with 25ml of the medium. 
         Overnight cultures of each isolate grown on SDA were transferred to the 
Tween 80 medium by touching the center of agar medium with a sterile cotton 
swab  to  prepare  a  circular  inoculation  site  about  10mm  in  diameter.  The 
inoculated agar plates were incubated at 30°c and were examined daily for 10 
days. 
 The presence of a halo around the inoculated site on Tween medium 
viewed with transmitted light indicated a positive test, that the isolate produced 
an  esterase.  The  fatty  acids  liberated  on  hydrolysis  of  Tween  80  bind  the 
calcium  incorporated  in  medium  to  form  a  visible  calcium  complex  of 
insoluble  crystal.  All  strains  of  C.albicans and  C.tropicalis produce  a  halo 
response within 2-3 days of inoculation. The isolates of  C.guilliermondii  and 
C. rugosa yield a halo at 3-9 days post inoculation and negative response for 
C.dubliniensis, 132,80   even after 10 days. 
 CHROM AGAR CANDIDA:
CHROMagar Candida (CAC) is a selective medium for the isolation of 
fungi that simultaneously provides direct differentiation and identification of 
several Candida spp. 
This medium contains agar 15gm, peptic digest of animal tissue 15gm, 
dipotassium hydrogen  phosphate  1gm,  chromogenic  substrate  11.22gm and 
chloramphenical  0.5gm  per  liter.  42.72  grams  of  CHROMagar  Candida 
(Himedia) was suspended in 1000 ml distilled water, and boiled to dissolve the 
medium completely. The medium was cooled to 50°C and poured into sterile 
Petri plates. The medium should not be autoclaved. 
A  suspension  of  yeast  was  made  from  an  overnight  culture  on 
Sabouraud’s dextrose agar and inoculated to CAC. The plates were incubated 
in atmospheric air at 37oC as recommended by manufactures. All cultures were 
read at 48 hrs. Colonies of  C.ablicans and  C.dubliniensis appear  lighter and 
darker  green,  respectively.C.tropicalis appear  with  a  blue  green  hue and 
C.krusei colonies appear light pink or white and dry with a light border. Other 
yeasts appear cream colored. 
CONFIRMATION OF THE CANDIDA SPECIES 
Morphology on Cornmeal agar with Tween 80 
 Sugar Assimilation test
 Tween 80 opacity test

MORPHOLOGY ON CORNMEAL AGAR WITH TWEEN 80 
The morphology and arrangement of the blastoconidia,  pseudohyphae 
and  the  hyphal  arrangements  were  observed  for  speciation  of  the  Candida 
isolated.
CARBOHYDRATE ASSIMILATION TEST
As  the  fermentation  tests  give  more  false  positive  results  due  to 
endogenous  carbohydrates,  assimilation  test was  performed  to  assess  the 
ability of the yeasts to grow in various single carbohydrate substrates. 
Procedure 
Yeast nitrogen-base agar(YNB):
2% agar solution was prepared, autoclaved for 15mins, at 121˚c at15psi. 
6.7gm of YNB (Himedia) was dissolved in 100ml of distilled water. The pH 
was adjusted to 6.2-6.4 by adding 1 N NaOH and filter sterilized. To 1 liter of 
2%  agar  solution,  88ml  of  YNB and  100ml  of  filter  sterilized  bromcresol 
purple indicator was added.                
A standardized suspension of yeast in saline equivalent to McFarland 
standard  4 was prepared.  It  was  allowed at  room temperature,  overnight  to 
exhaust their endogenous metabolites. Viability control of this inoculum was 
accompanied, by inoculating the suspension onto SDA and observed for the 
growth  of  the  yeast  isolate  at  37°c  for  24-  48  hours.(Gradwohl’s  Clinical 
Laboratory  Methods  and  Diagnosis,  8th edition,  Alex.  C.Sonnen  wirth. 
Leonardjarett pg. 2036) 3

With a sterile Pasteur pipette, the surface of the yeast nitrogenous base 
agar  plate  was  flooded.  Excess  suspension  was  aspirated  using  the  same 
pipette. The surface of the agar was allowed to dry for 5minutes. 
Glucose,  Galactose,  Lactose,  Maltose,  Sucrose,  Trehalose,  Xylose, 
Raffinose,  Cellobiose  and  Melibiose  carbohydrate  assimilation  (Himedia) 
disks were placed on the agar and pressed down firmly with the tip of flamed 
forceps.  The  disks  were  placed  sufficiently  far  apart  so  that  the  zone  of 
diffusion from one carbohydrate disk did not overrun the diffusion zone of 
another  (one  in  each  quadrant  and  one  in  the  center).65  The  plates  were 
incubated at 30°C for 24 hours. 
Result
A  positive  test  was  the  observation  of  visible  growth  around  the 
carbohydrate disk, indicating that the sugar contained has been assimilated by 
the yeast species under study. The size of zone or the density of growth around 
the disk is unimportant  (Elmer W. Koneman, Color Atlas & Text book of 
Diag.Microbiology 5th edition pg 1305).35 
ANTIFUNGAL SUSCEPTIBILITY TESTING (NCCLSM44-P) A.Barry, 1 
et.al. 11                       
Media preparation
Muller-Hinton (MH) agar was used for the antifungal susceptibility test. 
A stock solution of methylene blue (5 mg/ml) was prepared and refrigerated at 
2 to 8°C. To 100 ml of a 40% glucose solution, 200 µl of the stock methylene 
blue was added to give 10 mg of methylene blue per ml of 40% glucose to give 
10 mg of methylene blue per ml of 40% glucose (GMB solution). The glucose 
methylene blue (GMB) solution was dispensed into screw-capped tubes as 1.5 
ml/tube for 100-mm-diameter MH plates. The solution was then sterilized by 
autoclaving. 
Flooding procedure
The day before testing, refrigerated tubes with the GMB solution were 
allowed to warm to room temperature and at the same time MH agar plates 
were dried in a 35°C incubator with lids ajar until all of the surface moisture 
evaporated for1 to 2 hrs. The dried agar surface was then flooded with 1.5ml of 
GMB solution, and the liquid was allowed to adsorb at room temperature on a 
flat  surface  overnight.  Assuming  that  the  supplements  were  completely 
adsorbed and evenly dispersed throughout the agar in each 100-mm-diameter 
plate, the final concentrations of glucose and methylene blue was 2% and 0.5 
mg/ml, respectively.
Disk diffusion tests were performed by preparing a saline suspension of 
freshly isolated colonies  that  was then adjusted to  match the  turbidity  of  a 
McFarland 0.5 standard. A sterile applicator swab was moistened in this cell 
suspension and then used to inoculate the surface of each 150-mm-diameter 
agar plate. After inoculation of the plates the Fluconazole disk was applied to 
the surface. Also Nystatin, Clotrimazole, Ketoconazole, Itraconazole and 

Amphotericin B disks were applied to the surface of the agar with a distance of 
about 24mm for comparison. The inverted plates were then incubated at 35°C 
for 20 to 24 h. Kirby-Bauer scale were used to measure the diameter of each 
zone of inhibition at the point where there was a sharp decline in the density of 
growth.
Result
All strains tested for susceptibility were interpreted as belonging to one 
of three categories:91 
Susceptible: - strains for which zone diameters were ≥19 mm 
                      (Corresponding to MICs  ≤8 μg/ml)
Susceptible-dose dependent:-strains for which zone diameters were15 to18 mm
                                    (Corresponding to MICs 16 to 32 μg/ml)
 Resistant: - strains for which zone diameters were ≤14 mm
           (Corresponding to MICs were ≥64 μg/ml) 
RESULTS
 A  total  of  190  oropharyngeal  (OPC)  swabs  were  collected  from the 
patients of Radiotherapy unit (RT), Voluntary Counseling and Testing Center 
(VCTC) and Diabetic out patient department of Tirunelveli Medical College 
Hospital.
 In the radiotherapy unit,  90 OPC samples were collected from patients 
who had received External Beam Radio Therapy (EBRT) for malignancy of the 
oral cavity for a period of 15 days. In VCTC, 58 samples were taken from HIV 
infected individuals. In the Diabetic out patient department,  42  samples were 
taken from individuals who had uncontrolled diabetes mellitus for more than a 
year. (Table: 1) (Fig.1)
Table 1: Department and sex wise distribution of samples  
Department Male Female Total
Radiotherapy unit 54 (60) 36(40) 90
VCTC (HIV +ve) 30(51.7) 28(48.3) 58
Diabetology 34(81) 8(19) 42
Total 118 (62.1) 72 (37.9) 190
(Parenthesis denotes percentage)
Of the  190-study population,  118  (62.1%) were male and  72 (37.9%) 
were female. Among them 7 (3.7%) were < 20years, 14 (7.4%) were between 
21-30 years, 56 (29.5%) were between 31 - 40 years, 48 (25.3%) were between 
41-50 years,  33 (17.4%) were between 51-60 years and 32 (16.8%) were >60 
years. (Table 2)(Fig.2)
Table 2: Demographic character of the study population 
Age
Radiotherapy VCTC Diabetology
Total
M F M F M F
< 20 years --- --- 2 4 --- 1 7(3.7%)
21-30 --- --- 8 4 1 1 14(7.4%)
31-40 4 8 14 20 5 5 56(29.5%)
41-50 8 20 6 0 13 1 48(25.3%)
51-60 18 6 --- --- 9 0 33(17.4%)
>60 24 2 --- --- 6 0 32(16.8%)
Total 54 36 30 28 34 8 190
(Parenthesis denotes percentage)
PRIMARY  ISOLATION  OF  CANDIDA  SPECIES  FROM  CLINICAL 
SAMPLES
Grams staining and growth on Sabouraud’s dextrose agar (SDA)
When  190 oropharyngeal  (OPC)  swabs  were  examined  by  Grams 
staining and cultured on Sabouraud’s dextrose agar (SDA), 133 (70%) showed 
budding yeast  cells  on direct  examination and creamy growth on SDA.  In 
Grams staining 54 (40.6%) showed pseudohyphae. 
 Out of the 90 samples from the patients who had received radiotherapy, 
64 (71.1%) were positive for budding yeast cells and growth on SDA. Of the 
58 samples from the HIV infected individuals,  30  (51.7%) were positive for 
budding yeast cells and growth on SDA. Of the 42 samples from the diabetics, 
39 (92.8%)  were  positive  for  budding  yeast  cells  and  growth  on  SDA 
(Table 3) (Fig.3&3a). 
From the  Grams  smear  and  growth  on  SDA  133 (70%)  out  of  190 
samples were identified as Candida.
010
20
30
40
50
60
No
. o
f c
as
es
Male Female
Category
Fig. 1. Department and sex wise distribution of 
samples
Radiotherapy
HIV+ve
Diabetes 
0
5
10
15
20
25
No
.o
f C
as
es
RTmale RTfemale HIVmale HIV  
female
DM male DM
female
 Population Category 
Fig2.Demographic character of the study population
<20 years
21-30
31-40
41-50
51-60
>60
05
10
15
20
25
No
.o
f C
as
es
RTmale RTfemale HIVmale HIV  
female
DM male DM
female
 Population Category 
Fig2.Demographic character of the study population
<20 years
21-30
31-40
41-50
51-60
>60
Table 3: Isolation of Candida in Immunocompromised individuals  
Category Total No. of samples
Directs smear &
Growth on SDA
Male Female Total
Radiotherapy 90 42(65.6) 22 (34.4) 64(71.1)
HIV 58 10 (33.3) 20 (66.7) 30(51.7)
DM 42 31(79.5) 8(20.5) 39(92.8)
Total 190 83(62.5)
50
(37.5)
133
(70)
(Parenthesis denotes percentage)
RAPID IDENTIFICATION OF CANDIDA ALBICANS 
Germ tube test
 To confirm the identity as C.albicans the germ tube test was performed 
for all the  133 Candida isolates. Of the  133 isolates  68 (51.1%) showed the 
presence of germ tube and 65 (48.9%) showed no evidence of germ tube. 
Chlamydospore production on Cornmeal Tween 80 medium (CMA-T80):
  As a further confirmatory test, the 133 Candida isolates were grown on 
Cornmeal  agar  Tween80  medium  (CMA-T80)  for  the  production  of 
chlamydospores. 74 (55.6%) isolates produced chlamydospores and 59(54.4%) 
showed no chlamydospores on CMA - T80.  
Fig.3 & 3a. Isolation of Candida in 
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Chlamydospore production on Sunflower Seed Husk Agar 
 The  133 isolates from the SDA were cultured on the Sunflower Seed 
Husk  Agar  by  furrowing  technique  and  observed  for  the  production  of 
chlamydospores.  Only  4  (3%) isolates produced rough colonies with hyphal 
fringes  and  abundant  chlamydospores,  2 of  which  were  confirmed  as 
C.dubliniensis by further  tests.  The  remaining  129  (97%) isolates  produced 
smooth colonies with no evidence of chlamydospore production.  
Tween 80 opacity test
 In the Tween 80 opacity test, the  133 Candida isolates from the SDA 
were  cultured  (swabbing  technique)  and  observed  for  the  development  of 
opalescence  around  the  inoculation  site  due  to  the  activity  of  the  lipolytic 
enzymes, daily for 10 days. 
Of the 133 isolates, 105 (78.9%) developed opalescence within 3 days 
suggestive  of  the  species  C.albicans or  C.tropicalis. Of  this,  72(54.1%) 
isolates were identified as  C.albicans, as they showed the presence of germ 
tube  on  incubation  with  pooled  human  serum  and  production  of 
chlamydospores  on  Corn  meal  agar  with  Tween  80  (CMA-T80)  medium. 
33(24.8%) isolates were identified as C.tropicalis by the absence of germ tube 
and their morphology on CMA-T80 medium.
 3  (2.25%) isolates developed  opalescence within 3-9 days and were 
identified as C.lusitaniae by carbohydrate assimilation test. 
25 (18.8%) isolates did not develop opalescence even after 10 days of 
incubation. Of this  2(1.5%) isolates were identified as C.dubliniensis by the 
production of germ tube, and chlamydospores on CMA T 80 & SSHA medium. 
(Table 4 &5)(Fig.4&5).
Table 4: Lipolytic activities of Candida on Tween 80 Opacity medium.  
           Total No. of 
isolates tested
No. of Isolates +ve No. of Isolates - ve
2 – 3 
days
4 – 9 
days Total 10 – 12 days
133 105 3 108 25
Table 5: Lipolytic activities of various Candida spp. on a Tween 80     
                 Opacity medium.  
Species
Total No. of 
isolates 
tested
No. of Isolates +ve No. of Isolates - ve
2-3 
days
4-9 
days
Total 10-12 days
C.albicans 72 72 72 -
C. tropicalis 33 33 33 -
C.parapsilosis 7 - - - 7
C. kefyr 7 - - - 7
C. glabrata 6 - - - 6
C.guilliermondii 3 - 3 3 -
C.kusei 2 - - - 2
C.dubliniensis 2 - - - 2
C.lusitaniae 1 - - - 1
Total 133 105 3 108 25
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CHROMagar Candida 
 The chromogenic substrate incorporated in the CHROMagar  Candida, 
aided  in  the  speciation  of  Candida, on  the  basis  of  specific  colony  colour 
particularly,  for  C.albicans (light  green),  C.dubliniensis (dark  green), 
C.tropicalis (blue green hue) and  C.krusei (light pink to white) and other 
species (white).  Of the 133 isolates,  69 (51.9%) were light green,  5(3.75%) 
dark green, 29 (21.8%) with blue green hue and 30 (22.55%) white in colour. 
(Table 6)(Fig.6)
Table 6:  Isolation of Candida in CHROM agar Candida media
Colour No. of positive Isolates Species
Light Green 69 (51.9) C.albicans
Dark Green 5 (3.7) C. dubliniensis
Blue Green 29 (21.8) C. tropicalis
White 30 (22.5) Others
Total 133
(Parenthesis denotes percentage)
Confirmative test for C.albicans
Among the 133 isolates, sensitivity of the Germ tube test was 51.2%; 
chlamydospores on CMA T-80 55.6%; absence of chlamydospores on SSHA 
97%; Tween 80 Opacity test 81.3% and light green colonies on CHROM agar 
Candida 51.9%.
Table 7: Confirmative test for C.albicans
Name of the test
Positive Negative
No % No %
Germ tube Test 68 51.2 65 48.8
Chlamydospores +ve on CMA – T80 74 55.6 59 44.4
Chlamydospores +ve on SSHA 4     3  129    97
Tween-80 opacity Test   108 81.3   25  18.7
Light Green colonies on CHROM agar 
Candida    69 51.9 61 48.1
            CMA - T80 : Cornmeal agar with Tween - 80
            SSHA          :  Sunflower seed husk agar
Confirmation of Candida isolates 
The speciation of the  Candida isolates were confirmed finally by the 
Carbohydrate assimilation test, morphology on Corn meal agar, and  the 
Tween 80 opacity test together with the other identification tests elaborated.
Morphology on Cornmeal agar Tween – 80 
All the  133 Candida isolates from SDA were cultured on to cornmeal 
Tween  –  80  agar  for  identifying  the  morphology  and  arrangement  of  the 
blastoconidia,  chlamydoconidia,  pseudohyphae  and  hyphal  structures. 
(Table 8)  (Fig. 8) 
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Fig.8. Candida species based on CMA T80 Morphology
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Fig.9. Carbohydrate Assimilation Test
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Table 8: Candida species based on blastoconidia, pseudohyphae and 
                 hyphal morphology 
Morphology Species Total Percentage
Compact  clusters  of  blastoconidia 
(Intercalary  or  terminal)  at  regular 
intervals along pseudohyphae.
C.albicans 74 55.6
Abundant  pseudomycelium  composed 
of  elongated  blastoconidia  widely 
spaced, in single or small clusters along 
the hyphae.
C. tropicalis 41 30.8
Thin,  branching  pseudomycelium  with 
of  few ovoid to  elongate blastoconidia 
in  verticils.Thick  pseudomycelium and 
giant cells were also found.
C. parapsilosis 3 2.25
Abundant  pseudomycelium  with  very 
elongate blastoconidia, fell apart and lie 
parallel like logs in a stream. 
C. kefyr 3 2.25
No pseudomycelium.  Small  rounds 
yeast cells seen. C. glabrata 6 4.5
Short  pseudohyphae  with  clusters  of 
small blastoconidia C.guilliermondii 4 3
Elongated  blastoconidia  in  tree  or 
crossed match stick like appearance. C.krusei 2 1.5
Total 133
Carbohydrate Assimilation Test
Of the 133 Candida isolates 72(54.1%) were identified as C.albicans, 32 
(24%)  as  C.tropicalis, 7 (5.3%)  as  C.parapsilosis, 6 (5.3%)  as  C.kefyr, 6 
(4.5%) as  C.glabrata, 3 (2.25%) as  C.guilliermondii, 2 (1.5%) as  C.krusei, 
2(1.5%) as C.dubliniensis, 1 (0.75) as C. lusitaniae. (Table 9) (Fig.9)
Of the 133 isolates, 1(0.75%) isolate of C.tropicalis did not assimilate the sugar 
Galactose and 1(0.75%) isolate of C.kefyr did not. assimilate Xylose. 
Table 9: Carbohydrate Assimilation Test
(Parenthesis denotes percentage)
Distribution of Candida species among the clinical isolates
 Together with all the identification tests the 133 isolates were speciated 
as  72 (54.1%)as  C.albicans,  33 (24.8%)  as  C.tropicalis,  7 (5.3%)  as 
C.parapsilosis,  7  (5.3%)  as C.kefyr, 6 (4.5%)  as  C.glabrata,  3 (2.25%)  as 
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C.albicans +  - +  +  +  +  -  -  - 72(54.1)
C. tropicalis +  - + + + +  - +  - 32(24)
C.parapsilosis +  - + + + +  -  -  - 7(5.3)
C. kefyr +  - +  - +  - + +  - 6(4.5)
C. glabrata  -  -  -  -  - +  -  -  - 6(4.5)
C.guilliermondii +  - + + + + + + + 3(2.2)
C.krusei  - +  -  -  -  -  -  -  - 2(1.5)
C.dubliniensis +  - + +  - ±  -  -  - 2(1.5)
C.lusitaniae +  - + + + +  - +  - 1(0.75)
Total          133
C.guilliermondii, 2 (1.5%) as  C.krusei  ,  2(1.5%) as  C.dubliniensis,  1 (0.75%) 
as C. lusitaniae.(Table:10)(Fig.10)
Table 10: Distribution of Candida species among the clinical isolates
Sl. 
No
Species No. of Isolates Percentage 
1 C.albicans 72 54.1
2 C. tropicalis 33 24.8
3 C. parapsilosis 7 5.3
4 C. kefyr 7 5.3
5 C. glabrata 6 4.5
6 C. guilliermondii 3 2.2
7 C.krusei 2 1.5
8 C.dubliniensis 2 1.5
9 C.lusitaniae 1 0.7
Total 133 100
Identification of C.albicans – Comparison of test 
In the idenification of C.albicans, the sensitivity for Germ tube test was 
94.4%,  Chromagar  candida  95.8% and  Sunflower  Seed  Husk  Agar  97.2%. 
Whereas the sensitivity of chlamydospores on CMA – T 80, Tween 80 Opacity 
test & Carbohydrate assimilation test was 100%. (Table 11).
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Fig. 10. Distribution of Candida species among 
the clinical isolates
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Fig. 12.Category wise distribution of Candida species
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Table 11: Identification of C.albicans – Comparison of tests 
Identification test No. of C.albicans isolates +ve Percentage 
Grams strain+ve 72 100
Candida Species
ategory
RT HIV DM
(budding yeast cell)
Pseudohyphae + 54 75
Growth on S.D.A. 72 100
Germ tube Test 68 94.4
Chlamydospores +ve 72 100
Tween-80 opacity Test 72 100
Sun flower seed husk agar
(Chlamydospores +ve)
70       97.2
C.A.C 69       95.8
Assimilation 72 100
Category wise distribution of Candida species 
Among the 133 isolates,  C.albicans-72 (54.1%) was the predominant 
species,  followed  by  C.tropicalis-33(24.8%),  C.parapsilosis-7(5.3%),  and 
C.kefyr-7 (5.3%) C.glabrata -6 (4.5%), C.guilliermondii - 3 (2.25%), C.krusei  
-2 (1.5%), C.dubliniensis-2(1.5%) and C. lusitaniae 1 (0.75%).  
In individuals who had been on radiotherapy  C.albicans (62.5%) was 
the predominant species followed by C.tropicalis (28.1%).
In  the  HIV  infected  individuals  also  C.albicans(80%) was  the 
predominant species followed by C.tropicalis (6.7%).
In the diabetics C.tropicalis (33.3%) was the predominant one followed 
by C.albicans (20.5%). 
In the post radiotherapy patients  non-albicans constituted  37.5%, in HIV 
infected  individuals  it  was  19.9% and in  diabetics  it  was  79.5% 
(Table: 12) (Fig.12)
Table 12: Category wise distribution of Candida species 
Sex wise distribution of Candida species 
Isolation  of  C.albicans was  almost  equal  among  both  sexes  (51:49) 
whereas  C.tropicalis was  more  in  males.  Non-albicans (61)  were 
predominantly  isolated  from the  male  (72.1%)  population  than  the  females 
(27.9%). (Table 13) (Fig. 13)
Species
Department
Total
R.T HIV DM
C.albicans 40(62.5%) 24(80%) 8(20.5%) 72 
C. tropicalis 18(28.1%) 2(6.7%) 13(33.3%) 33
C. parapsilosis 2(3.1%) 0 5(12.8%) 7
C. kefyr 2(3.1%) 4(13.3%) 1(2.6%) 7
C. glabrata 2(3.1%) 0 4(10.2%) 6
C. guilliermondii 0 0 3(7.7%) 3
C.krusei 0 0 2(5.1%) 2
C.dubliniensis 0 0 2(5.1%) 2
C.lusitaniae 0 0 1(2.6%) 1
Total 64 30 39 133
Table 13: Sex wise distribution of Candida species 
Species Male Female Total
C.albicans 37(51.4) 35(48.6) 72
C. tropicalis 24(72.7) 9(27.3) 33
C. parapsilosis 6(85.7) 1(14.3) 7
C. kefyr 5(71.4) 2(28.6) 7
C. glabrata 3(50) 3(50) 6
C. guilliermondii 2(66.7) 1(33.3) 3
C.krusei 1(50) 1(50) 2
C.dubliniensis 2(100) 0 2
C.lusitaniae 1(100) 0 1
Total 81 52 133
(Parenthesis denotes percentage)
Age wise distribution of Candida species 
The isolation of C.albicans was more in the age group 31-40years (33.3%), 
and that of non-albicans in the age group 51-60years (29.5%). The 2 
C.dubliniensis  were  isolated  from  the  age  >60years (1.5%). 
(Table:14) (Fig.14)
 
Table 14: Age wise distribution of Candida species 
Species
Below
20
21-30 31-40 41- 50 51- 60 Above 60 Total
C.albicans 6(8.3) 0 24(33.3) 14(19.4) 10(13.8) 18(25) 72
C.tropicalis 0 3(9.1) 4(12.1) 12(36.4) 9(27.3) 5(15.1) 33
C.parapsilosis 0 1(20) 2(40) 2(40) 2(28.5) 0 7
C.kefyr 0 0 4(57.1) 1(14.3) 2(28.5) 0 7
C.glabrata 0 0 1(16.7) 0 3(50) 2(33.3) 6
C.guilliermondii 0 1(33.3) 1(33.3) 0 1(33.3) 0 3
C.krusei 1(50) 0 0 0 1(50) 0 2
C.dubliniensis 0 0 0 0 0 2(100) 2
C.lusitaniae 0 0 1 0 0 0 1
Total
7 
(5.3)
5
(3.7)
37
(27.8)
29
(21.8)
28
(21)
27
(20.3)
133
(Parenthesis denotes percentage)
Anti fungal susceptibility test 
Of the  72 C.albicans, 61 (84.7%) were susceptible to Fluconazole,  70 
(97.2%)  to  Itraconazole,  69(95.8%)  to  Ketoconazole,  71(98.6%)  to 
Clotrimazole, 69 (95.8%) to Nystatin, and 71 (98.6%) to Amphotericin B. 
Of  the  33 C.tropicalis, 28(84.8%)  were  susceptible  to  Fluconazole, 
31(93.9%)  to  Itraconazole,  32(97%)  to  Ketoconazole,  30 (90%)  to 
Clotrimazole, 30(90%) to Nystatin, 32(96%) to Amphotericin B.
Among the7 C.parapsilosis, 6(85.7%) were susceptible to Fluconazole, 
6(85.7%)  to  Itraconazole,  6(85.7%)  to  Ketoconazole,  5(71.4%)  to 
Clotrimazole, 5(71.4%) to Nystatin, and 7(100%) to Amphotericin B. 
Of the 7, C.kefyr 5(71.4%) were susceptible to Fluconazole, 5(71.4%) to 
Itraconazole,  5(71.4%) to Ketoconazole,  5(71.4%) to Clotrimazole,  5(71.4%) 
to Nystatin, and 7(100%) to Amphotericin B.
Among the  6 C.glabrata 1(16.7%) were susceptible to Fluconazole,  6 
(100%) to Itraconazole, 1(16.7%) to Ketoconazole, 1(16.67%) to Clotrimazole, 
3(50%) to Nystatin, and 6(100%) to Amphotericin B.
Of the  3 C.guilliermondii,  all  were 100% susceptible to Fluconazole, 
Itraconazole, Ketoconazole, Clotrimazole, Nystatin, and Amphotericin B.
Among the 2 C.Krusei, both were only susceptible to Amphotericin B Of the 2 
C.dubliniensis, both were only susceptible to Amphotericin B. C.lusitaniae was 
susceptible to all except Fluconazole. (Table: 15) 
The over all antifungal susceptibility for the Candida isolated was 78.19 
for Fluconazole, 94.7% for Itraconazole, 89.4% for Ketoconazole, 87.2% for 
Clotrimazole, 87.2% for Nystatin and 96% for Amphotericin –B.
Of  this,  the  susceptibility  of  C.albicans was  84.7% for  Fluconazole; 
97.2%  for  Itraconazole;  95.8%  for  Ketoconazole;  98.6%  for  Clotrimazole; 
76.4% for Nystatin and 98.6% for Amphotericin –B.
The susceptibility of non-albicans was 70.5% for Fluconazole; 91% for 
Itraconazole; 82% for Ketoconazole; 73.5% for Clotrimazole; 69% for Nystatin 
and 90.3% for Amphotericin –B.
Table 15: Anti fungal susceptibility pattern of the Candida 
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C.albicans
72 61
(84.7)
70
(97.2)
69
(95.8)
71
(98.6)
55
(76.4)
71
(98.6)
C. tropicalis 
33 28
(84.8)
31
(93.9)
32
(97)
30
(91)
26
(78.8)
32
(97)
C.parapsilosis
7 6
(85.7)
6
(85.7)
6
(85.7)
5
(71.4)
5
(71.4)
7
(100)
C. kefyr
7 5
(71)
5
(71.4)
5
(71.4)
5
(71.4)
5
(71.4)
7
C. glabrata
6 1
(16.6)
6
(100)
1
(16.7)
1
(16.7)
2
(33.3)
6
(83.3)
C.guilliermondii
3 3
(100)
3
(100)
3
(100)
3
(100)
3
(100)
3
(100)
C.krusei 
2 0 2
(100)
0 0 0 2
(100)
C.dubliniensis
2 0 2
(100)
2
(100)
0 0 2
(100)
C.lusitaniae 1 0 1(100)
1
(100)
1
(100)
1
(100)
1
(100)
Total
133 104
(78.2)
126
(94.7)
119
(89.4)
116
(87.2)
97
(72.9)
128
(96.0)
(Parenthesis denotes percentage)
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Fig. 13.Sex wise distribution of Candida species
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Fig.14. Age wise distribution of Candida Species 
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Fig. 15.Antifungal Susceptibility 
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DISCUSSION
The incidence of fungal infections has increased steadily over the past 
decade, due to the increase in  Candida spp. other than  C.albicans.Although 
C.albicans remains the most common species encountered as a cause of human 
infections,  other  Candida spp.  have  been  increasingly  associated  with 
disseminated disease  since the 1990.  Since candidemia is  associated with a 
high mortality rate,  prompt appropriate antifungal therapy is essential in the 
immunocompromised.
A total of  190 clinical samples were collected from the Radiotherapy 
unit, Voluntary Counseling and Testing Center(VCTC), and the Diabetic Out 
patient Department of Tirunelveli Medical College Hospital for a period of 18 
months  to  study  the  prevalence  of  oropharyngeal  candidiasis(OPC)  in  the 
immunocompromised,  to  speciate  the  isolates  and  to  find   their  antifungal 
susceptibility patterns. 
In the present study, among the 190 study population, the occurrence of 
oropharyngeal candidiasis (OPC) was  133(70%),  of which  64 (71.1%) were 
from  the  patients  who  had  received radiotherapy  for  oropharyngeal 
malignancies, 30 (51.7%) from HIV infected individuals and 39 (92.8%) from 
diabetic patients.
In our study the incidence of oropharyngeal candidiasis (OPC) was more 
(71%)  among the  patients  who  had  received  radiotherapy  compared  to  the 
study of  Spencer W Redding  et al.149  & Finlay.et.al.1996.43which was about 
17  to  29%.  Ramirez-Amador  V et.al.,114  also  studied  that  radiotherapy 
encourages  oral  Candidal colonization  and  17.4%  developed  clinical 
candidiasis during radiotherapy. The present study correlates to the study of 
Spijkervet FK et al.,150 with an incidence of 64%.
 In the present study, the incidence of oropharyngeal candidiasis (OPC) 
among the HIV infected individuals was 51.7%. This correlates with the study 
of Chien–Ching Hung  et  al.,24 were  >50% of the HIV-infected outpatients 
were  colonized  with  Candida spp.  and  12%  developed  symptomatic 
candidiasis. 
In our study, among the HIV infected individuals 16(53.3%) had CD4 
counts <200cells/mm3. This is supported by the study of  Feigal D W et al.,41 
who  demonstrated  that  progressive  cell  mediated  immunodeficiency,  with 
CD4+ counts <200cells/mm3, is a risk factor for colonization with Candida spp. 
and the development of candidiasis. In particular OPC occurs in up to 90% of 
patients during the course of HIV infection.22 Fichtenbaum C J, Koletar S    et 
al., studied that up to 90% of persons with advanced untreated HIV infection 
developed OPC, with 60% having at least 1 episode per year with frequent 
recurrences (50-60%).
In our study, the association of diabetes and oropharyngeal candidiasis 
was about  92.8%, which is in favour of  Knight l  et al., 72 who demonstrated 
that diabetics are more susceptible to candidiasis with an incidence of 67%. 
This is also supported by Vazquez J A  and J D Sobel  et al., 1995,161 who 
observed  OPC mostly in diabetics (71%) with poorly controlled blood sugar 
levels. This was also supported by Anton Y Peleg, Thilak Weerarathna et al., 
& Soysa N S, Samaranayake L P, and Ellepola A N B et al.,8 who showed an 
incidence of 82%. 
In  this  study,  the  incidence  of  oropharyngeal  candidiasis  (OPC) was 
83(62.4%) in male and 50(37.6%) in female.  The high incidence in male was 
associated with the habit of smoking (94%) and alcoholism (78%) in males. 
This is in favour of the study by Epstein J B et al.,38 who showed smoking and 
alcoholism as risk factors for oral colonization by  Candida during radiation 
therapy as 87%.
 When the age factor was taken into consideration, the incidence of OPC 
was more in the age group  >60years (37.5%) in patients who had received 
radiotherapy. But the incidence was more in the age group 31-40 years in the 
HIV  infected (73.3%) and the diabetics (35.9%). This is in accordance with 
Benito Almirante & Dolrs Rodriguez et al.,12 a population based surveillance 
were the age specific incidence rate was highest in infants (38.8 cases/100,000 
population)and  in  those  aged  >  65  years  (12cases/100,000  population)  for 
blood stream Candida infections.
Grams Staining and Growth on SDA
In the present study among the  190 immunocompromised population, 
the  occurrence  of  oropharyngeal  candidiasis  (OPC)  was  identified  as 
70%(133),  by  direct  examination  (Grams  stain)  of  the  smears  from  the 
oropharyngeal  lesions  for  the  presence  of  budding  yeast  cells  and  by  the 
characteristically large, butyrous colonies on Sabouraud’s dextrose agar(SDA). 
In Grams staining 40.6% (54) showed the presence of pseudohyphae.
Germ tube test
Of the 133 (70%) Candida isolated from SDA, 68(51.1%) showed the 
presence of germ tube on incubation with pooled human serum. In our study 
among the 72 isolates identified as C.albicans, 68 (94.4%) produced the germ 
tube. This is in accordance with study of Salkin L, and Hurd NJ et al.,142  in 
which about 95% of C.albicans produced germ tube and 5% showed no germ 
tube production.
Chlamydospore production on Cornmeal Tween 80 medium (CMA-T80)
When the 133(70%) isolates were cultured on CMA T80 medium, 74 
(55.6%) showed the production of chlamydospores. Of this 72 were identified 
as C.albicans in our study, which is in accordance with Murray P R, et al., in 
the Manual of Clinical Microbiology, 6th edition. 89 
Chlamydospore production on Sun Flower Seed Husk Agar (SSHA)
When the 133(70%) isolates from SDA were cultured on SSHA, 4(3%) 
isolates  produced  rough  colonies  with  hyphal  fringes  and  abundant 
chlamydospores, of which 2 were confirmed as  C.dubliniensis by other tests. 
The  remaining  129  (97%)  produced  smooth  colonies  with  no  evidence  of 
chlamydospores  and  were  confirmed  by  further  tests  as  C.albicans. This 
parallels  the  study  of  Khan  ZU  et  al., 70 & Pinjon  E  et  al.,107 where  all 
C.  dubliniensis isolates  produced  rough  colonies  with  hyphal  fringes  and 
abundant chlamydospores whereas 96.2%C.albicans isolates produced smooth 
colonies with no evidence of chlamydospore production.
Tween 80 opacity testing 
In  our  study  among  the  133  Candida isolates,  105(78.94%)  isolates 
developed opalescence around the inoculated site within 3 days on the Tween 
80 medium. Of the 105 isolates, 72(54.13%) were C.albicans and 33(24.81%) 
C.tropicalis as confirmed by the other tests.  No opalescence was seen even 
after 10 days for 25(18.79) isolates which were identified as C.dubliniensis(2),  
C.parapsilosis(7), C.kefyr(7),  C.krusei(2),  C.guilliermondii(3), C.lusitaniae(1) 
and C.glabrata (6) by the other identification tests. This parallels with the study 
of Rudek  W132 & Malcolm  Slifkin80 who  observed  that  C.albicans  and 
C.tropicalis produced  opacity  within  3  days  in  all  the  15  isolates  tested, 
C.guilliermondii (5)  and  C.rugosa (3) produced  opacity  in  3-9  days  and 
C.dubliniensis (16) and other Candida (52)  did not produce opacity even after 
10days.
CHROM agar Candida (CAC)
In our study when the 133 isolates were  grown on CAC,  69(51.9%) 
isolates  produced light  green color  colonies,  5(3.7%)  dark green colonies, 
29(21.8%) blue green colonies and 30(22.5%) white colonies
Of  the  72  C.albicans confirmed  by  other  tests,  only  69(95.83%). 
produced light green color and the remaining 3(4.1%) isolates produced dark 
green color. 
Of  the  33  C.tropicalis confirmed  by  other  tests,  only  29(87.87%) 
produced blue green colonies and 3(9.09%) produced white colonies. 
Of  the  25  white  colonies  7  C.parapsilosis,  7  C.kefyr, 2  C.Krusei, 3 
C.guilliermondii,  1  C.lusitaniae,  6  C.glabrata were  identified  by  the  other 
confirmatory tests. This is in favour of the studies conducted by  Hospenthal 
DR et al.,66 & Murray CK et al.,90 who showed similar results.
Morphology of blastoconidia, pseudohyphae and hyphae on CMA T80
When  the  133  isolates  were  cultured  on  CMA  T80  to  observe  the 
morphology  (blastoconidia,  pseudohyphae  and  hyphae),  74(55.6%)  showed 
compact clusters of small, round blastoconidia at regular intervals along the 
pseudohyphae  and  also  thick  walled  chlamydospores  either  intercalary  or 
terminal, in favour of  C.albicans. Of this  2(1.5 %) isolates showed terminal 
chlamydospores in bunches of doublets and triplets favouring the morphology 
of C.dubliniensis.
Abundant  pseudomycelium  composed  of  elongated,  widely  spaced 
blastoconidia in or small clusters along the hyphae were noticed in 41 (30.8%) 
isolates which is in favour of  C.tropicalis according to Rippon JW Medical 
mycology pg 517.139
Thin  branching  pseudomycelium  with  verticals  of  few  ovoid 
blastoconidia,  few thick  pseudomycelium and  giant  cells  were  observed  in 
3(2.2%)  isolates  is  in  favour  of  C.parapsilosis according  to Rippon  JW 
Medical mycology pg 517. 139
Abundant  pseudomycelium  with  very  elongated  cells  lying  apart  in 
parallel like logs in a stream appearance was noticed in 3(2.2%) of the isolates 
favouring the identification as C.kefyr as described in Koneman, Color Atlas 
and Diagnostic Microbiology 5th edition pg 1043. 34
In  6(4.5%) of the isolates only small round yeast  cells  were noticed. 
There was no pseudomycelium observed favouring the species C.glabrata as 
described by Rippon JW Medical mycology pg 517. 139
Short pseudohyphae with clusters of small blastoconidia were seen in 
4(3%) of the isolates in favour of C. guilliermondii as mentioned in Rippon. 
JW Medical mycology pg 517. 139
Elongated  cells  in  treelike  arrangement  with  elongated  blastoconidia 
was  noticed  in  2(1.5%)  of  the  isolates  suggesting  the  species  C.krusei 
according to Rippon. JW Medical mycology pg 517. 139
Of  the  41(30.82%)  isolates  suspected  as  C.tropicalis 4 (3%)  were 
confirmed as C.parapsilosis and 4(3%) as C.kefyr by the assimilation studies. 
Similarly  of  the  4(3%) isolates  identified as  C.guilliermondii 1(0.75%) was 
confirmed as C.lusitaniae.
Carbohydrate assimilation tests
In the present study the assimilation pattern of the yeast isolates were 
consistent with that of the standard assimilation pattern,  as described in the 
Elmer Koneman, Color Atlas and Text Book of Diagnostic Microbiology, 
5th edition, 1043 34 with few variations.
Of the 133 Candida isolates 72(54.13%) were identified as C.albicans, 
32 (24.8%) as C.tropicalis, 7 (5.26%) as C.parapsilosis, 6 (4.5%) as C.kefyr, 6 
(4.5%)  as  C.glabrata, 3 (2.2%)  as  C.guilliermondii, 2 (1.5%)  as  C.krusei, 
2(1.5%)  as  C.dubliniensis,  1 (0.7%)  as  C.  lusitaniae. 1(0.07%)  isolate  of 
C.tropicalis did not assimilate the sugar Galactose and 1(O.O7%) isolate of 
C.kefyr did not assimilate Xylose.
Prevalence of the Candida species:
 In the present study conducted at Tirunelveli Medical College Hospital, 
the  prevalence  of  C.albicans  (54.1%)  was  more  among  the  immuno-
compromised followed by C.tropicalis24.8%, C.parapsilosis and C.kefyr each 
constituted 5.26%, C.glabrata 4.51%,  C.guilliermondii 2.25%,  C. krusei  and 
C.dubliniensis each 1.5% and  C.lusitaniae 0.75%. This is in accordance with 
the study of Luis Octavio Sanchez- Vargas et.al.79  who showed an incidence 
of 63.7%
In  this  study, C.albicans 72(54.1%)  and  C.tropicalis 33(24.8%) 
constituted 84.2% of the total. This is favoured by Rippon D.W., in Medical 
Mycology; Candidiasis  and the pathogenic  yeast,  pg 536  141 as these two 
species together account for about 80% of the isolates from medical specimens.
 In  our  study  non–albicans constituted  61(45.86%),  of  which 
C.tropicalis was  33 (24.8%).  This  is  in  favour  of  Luis  Octavio  Sanchez- 
Vargas et al., 79 who in their study of oral candidiasis in HIV infected, isolated 
66.7% of Candida, of which. 27% were non-albicans spp. C.glabrata (18.7%) 
was  the  most  frequent  non-albicans followed  by  C.tropicalis (5.9%), 
C.parapsilosis (1.1%).
 Our observation was in contrast to the study of Fidel P L, Vazquez J A 
and Sobel J D 44  who reported that C.glabrata was the second most frequently 
isolated Candida spp. from clinical specimens after C.albicans. 
In this study,  C.albicans was the predominant species in patients who 
had received radiotherapy (62.5%) and in HIV infected individuals (80%).In 
the diabetics C.tropicalis (33.3%) was the most frequent species isolated. This 
was favoured by Winegard JR , Merz W G and Saral R et al.,169 observation 
of C. tropicalis (40-80%) as major pathogen in immunocompromised patients. 
In our study, the prevalence of C.albicans was almost equal in both the 
sexes (51.4:48.6), where as in C.tropicalis it was 3:1.
Antifungal susceptibility test
In our study  84.7%  C.albicans showed susceptibility for  Fluconazole 
and > 95% for Itraconazole, Ketoconazole, and Amphotericin B.The overall 
susceptibility of non-albicans for Fluconazole is 70.5%. This is in favour of 
Fichtenbaum CJ, Koletar S et al., 42 where overall, the rates of Fluconazole 
susceptibility was 81%.
In our study, susceptibility to Clotrimazole was noted to be 87.2% and 
this is in favour of the study by  Pelletier, Joanne Peter  et al., 102 where the 
susceptibility was 70-96%. This is also supported by Hood S, Evans J et al., 65 
whose study showed a susceptibility of 50-63%.
In  the  present  study,  only  83.3% of  C.glabrata  and the  2  isolates  of 
C.krusei  were  resistant  to  Fluconazole  in  favour  of  the  study  by  Pfaller 
et al.,  104 where  C.glabrata and  C.krusei  have been observed to be 4-fold to 
32-fold less susceptible than C.albicans to Fluconazole.
The rates of ketoconazole and Itraconazole resistance in our study was 
10.5% which was supported by He X, Tiballi  RN, Zarins LT, et al.,60who 
reported 0% to 25% resistance in their study.
Similarly our study showed resistance to Amphotericin as 1.5% which 
correlates  well  with  the  study of  Ruhnke M, Eigler  A,  et  al.,133 where the 
resistance was 1.3%. 
In  our  study,  C.lusitaniae was  susceptible  to  Amphotericin  –  B  in 
accordance  with  Chien-Ching  Hung,  Yun-Liang  Yang  et  al.,24 where  the 
susceptibility was 100%.  But our study was in contrast to the study of  Hand 
field  et  al., 59 where  C.lusitaniae was  reported  to  be  relatively  resistant  to 
Amphotericin – B (0.4%) and Fluconazole (2.3%)
                            SUMMARY
This  prospective  study  was  conducted  to  evaluate  the  prevalence  of 
Candida species among the immunocompromised individuals, mainly patients 
who had received radiotherapy for oropharyngeal malignancies, HIV infected 
individuals and diabetic patients.
The present study revealed that occurrence of oropharyngeal candidiasis 
was  more in patients with uncontrolled  Diabetes mellitus (92.8%) compared 
to  71.1%  of  the  post  radiotherapy  patients  and  52.7%  of  HIV  infected 
individuals.
The incidence of oropharyngeal candidiasis was more in males (60.9%) 
attributed to the risk factors of smoking and alcoholism.
The overall incidence of oropharyngeal candidiasis was more in the age 
group 31-40 years (27.8%). The incidence was more in the age group>60 years 
(37.5%)  in  the  radiotherapy unit,  and  31-40  years (73.3%)  in  the  HIV 
infected individuals and 41-50years (35.9%) in diabetic patients.
Among  the  immunocompromised  individuals  C.albicans was  the 
predominant  species  in  patients  who had radiotherapy (62.5%)  and in  HIV 
infected  individuals  (80%);  whereas  C.tropicalis (33.33%)  was  the 
predominant species in the diabetics.
The  prevalence  of  C.albicans was  almost  equal in  both  the  sexes 
(51:49), where as that of C.tropicalis was 3:1.
The incidence  of  C.albicans was  high  in  the  age  group 31-40 years 
(33.3%) and that of non-albicans was in the age group 51-60 years (29.5%).
Of  the  total  190 OPC samples  collected,  133(70%)  showed budding 
yeast cells on direct smear with Grams stain and growth on SDA
Of the  133  Candida isolates,  68(51.1%) showed the  presence  of  the 
germ tube, 74(55.6%) showed the production of chlamydospores on Corn Meal 
Agar  Tween80  (CMA-T80)  medium,  4(3%)  showed  the  production  of 
chlamydospores on Sun flower Seed Husk Agar SSHA, 108(81.3%) produced 
opacity  in  Tween  80  medium.  From  this  72(54.1%)  were  identified  as 
C.albicans and 2(1.5%) as C.dubliniensis.
Speciation of the 133 isolates was done by observing the 
 Morphology on Cornmeal agar-Tween 80 medium 
 Chlamydospores on Sunflower Seed Husk Agar medium 
 Development of opacity on the Tween 80 medium
 Specific colour  on CHROM agar Candida medium; 
 Carbohydrate  assimilation  pattern  on  sugar  free  Yeast 
nitrogen base medium.
 Of  the  133  isolates  72 (54.1%)  were  identified  as  C.albicans and 
61(45.8%)  were  non–albicans.Among  the  non–albicans 33(24.8%)  were 
C.tropicalis;  7(5.7)  C.parapsilosis;  7  (5.7)  C.kefyr;  6  (4.5%)  C.glabrata;  3 
(2.2%) C.guilliermondii; 2(1.5%) C.Krusei; 2(1.5%) C.dubliniensis; 1 (0.75%) 
C.lusitaniae.
Of  the  133 Candida  isolates  78.2% were susceptible  to  Fluconazole; 
94.7% to Itraconazole, 89.4% to Ketoconazole, 87.2% to Clotrimazole, 72.9% 
to Nystatin and 98% to Amphotericin –B.
Among C.albicans 84.7% were susceptible to Fluconazole and in non-
albicans 70.5% were susceptible to Fluconazole.
CONCLUSION
As C. albicans is a normal human commensal, it is not surprising that 
this  organism  is  the  most  common  opportunistic  fungal  pathogen in 
immunocompromised  patients.105Colonization  of  the  oropharynx and/or  the 
alimentary tract often precedes invasive yeast infections. 
The  incidence  of  oropharyngeal  candidiasis  is  high among  the 
diabetics. 
The  males are  more affected  due  to  the  associated  risk  factors  like 
smoking, alcoholism and tobacco chewing.
The age group above 30yrs is at high risk of developing oropharyngeal 
candidiasis.
C.albicans is  the  most  frequent species  isolated  from  the  post 
radiotherapy  patients  and  HIV  positive  individuals.  C.tropicalis is  the 
predominant species in the diabetics. 
Direct  microscopy  using  Grams  stain  and  primary  isolation  on 
Sabourauds dextrose agar is the most simple, economic and easy method for 
the isolation of the Candida.
Early identification of C.albicans is by,
 Germ tube test
 Production of chlamydospores  on the Corn meal Tween 80 
 Absence of chlamydospores on Sunflower Seed Husk Agar medium
 Opalescence  within 3 days on the Tween 80 opacity medium
 Specific  light  green colour  colonies  on  the  CHROMagar Candida 
medium.
The confirmation of the  Candida species is by the morphology on the 
semi starvation medium Corn Meal Agar with Tween 80 and the Carbohydrate 
Assimilation pattern on the carbohydrate free, Yeast nitrogen base medium. 
 The  resistance  of  non-albicans (28.5%)  to  Fluconazole  is  more 
compared to that of C.albicans (15.3%) 
The  resistance to Itraconazole is  less compared to Fluconazole,2.8% 
for C.albicans and for non- albicans is 8.2%.
The resistance to Amphotericin B is1.5%.
Early identification of the newly emerging spp. C.dubliniensis is by
Production of chlamydospores on Sun flower Seed Husk Agar
Absence of opalescence on the Tween 80 opacity medium
Specific dark green colour colonies on CHROMagar Candida medium.
In ability to assimilate Xylose.
SUGGESTION 
The  oral  manifestations  of  oropharyngeal  infection  in 
immunocompromised patients present a particular challenge for both medical 
and dental professionals as accurate diagnosis and appropriate treatment may 
be difficult. Effective control of infection is achieved by the judicious use of 
topical and systemic agents.
 Therefore the isolation and identification of Candida spp.from clinical 
specimens are very essential in deciding the antifungal of choice.
 Strategies  for  antifungal  prophylaxis  in  cancer  patients  receiving 
intensive  cytotoxic  chemotherapy and radiotherapy  have  been based on the 
principle of reducing fungal colonization in the oropharynx and/alimentary tract 
in  order to  reduce  systemic  invasive  fungal  infections  during  the  period  of 
greatest risk due to profound neutropenia. 
Strategies to prevent severe candidal infections should be effective and 
safe,  should  not  be  associated  with  high  likelihood  for  development  of 
resistance to antifungal agents. The best strategy should focus on identification 
of  the  target  population  (those  at  risk  for  developing  severe  candidiasis), 
implementing simple but effective control measures,  and when it  is needed, 
providing antifungal chemoprophlaxis.
The  choice  of  antifungal  agent  for  prophylaxis  in  this  population 
remains  controversial.  However,  azole  compounds  such  as  Clotrimazole, 
Ketoconazole and Fluconazole and Amphotericin B appear to be more effective 
and better tolerated than Nystatin suspension. Reents S,  Goodwin SD,  Singh V 
et al. 125
There is increasing evidence that prophylactic systemic azole antifungal 
can effectively reduce overall oral fungal colonization levels and reduce the 
risk  of  oral  candidiasis,  with  fluconazole  being  the  agent  of  choice. Oral 
Complications of Chemotherapy and Head/Neck Radiation -US National 
Cancer Research Institute, 2006. 99
The  key  economic  advantage  of  prophylaxis  with  fluconazole  or  a 
combination of fluconazole with oral polyenes results from the reduction of the 
expected cost of subsequent fungal infection among those who are most at risk. 
Wakerly L  et al. 162
Systemic antifungal chemotherapy can be associated with toxicity, cost, 
and emergence of resistance. An alternative approach is to give pre-emptive 
antifungal therapy, which consists of limiting antifungal therapy only to those 
patients at risk for serious candidal infections and who also exhibit evidence of 
significant colonization with candida spp. at two or more sites. This strategy 
has been proposed in the setting of cancer chemotherapy 160 and surgery.
 More  recent  data,  suggest  that  in  the  setting  of  extreme  immune 
debilitation,  a  change  in  epidemiology  of  candidiasis  has  occurred  with  a 
reduction  in  the  rates  of  C.albicans  in  favour  of  the  non  albicans  spp.  in 
particular  C.glabrata,  C.krusei,  C.parapsilosis and  C.tropicalis. 167 Whether 
these changes are a consequence of increased immuno suppression, the use of 
prophylactic  antifungal  treatments  or  absence  of  adequate  infection  control 
measures is uncertain.
In  general,  routine  prophylaxis  of  mucosal  candidiasis,  particularly 
OPC, has been discouraged.6
It should also be kept in mind that the best therapy for OPC is not an 
antifungal agent, instead 
 Prevention of mucosal breakdown
 Suppression of microbial colonization
 Control of viral reactivation
Up to 58% of health care workers can carry candida spp. on their hands 
154 and transmission from staff to patients and from patient to patient has been 
documented in several studies. Strict hand washing remains the most simplest 
and effective means to prevent the acquisition of organisms by patients. 2,47
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